ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000365.1|Glycopeptidolipid_1 # 3 # 746 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.629	BGC0000365.1|Glycopeptidolipid_1 	3	746	+	Loose	1900	28.4906	MexW	27.03	3003031	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	CAACGTGGTGATCCGGCGACGCCGGAGGGTATTGCGTTGGTCGAGCCCATCCGGGTGGCGGCAGAAGAAGCCCTCAAGGGCACACCGCTGGAAAGTGCAGAGTTGCATCTCGCCGGGACCGCAGCGGGGGTCAAGGATCTGGTCGACGGGTCGAAGATCGACCTGCTGATCGCGGGTGTCGCTGCGCTTTGCCTGATCTTCATCATCATGCTGATCATGACGCGGAGCTTCATCGCCGCGCTGGTCATCGTGGGCACCGTAGCGATGTCGCTGGGCGCATCGTTCGGGCTTTCGGTGCTGGTGTGGCAGCATCTGCTGGGCATCCAGATCAACTGGGTCGTGCTGGCGATGTCGGTCATCGTTCTCCTGGCAGTCGGGTCGGACTACAACCTGCTGCTCGTGTCCCGGATGAAAGAAGAGATAGGCGCCGGCTTGAACACCGGCATCATCCGAGCAATGGGCGGAACCGGAAAGGTCGTCACCGCGGCAGGTCTGGTCTTCGCAGCCACGATGGCGTCGATGATCGTCAGTGATCTGCTCACCATCGGTCAGGTCGGCACGACGATCGGTCTGGGTCTGCTGTTCGACACCTTGGTCGTGCGTGCTTTCATGACACCGTCCATCGCAGCCCTTCTGGGGCGTTGGTTCTGGTGGCCGCAGCGTGTGCGTCAGCGTCCCGCCAGCGCGATGCTCCGCTCCGTCGGCCCACGCCCCCTGGTGCGATCCCTGTTACTGAGGGATTAG	QRGDPATPEGIALVEPIRVAAEEALKGTPLESAELHLAGTAAGVKDLVDGSKIDLLIAGVAALCLIFIIMLIMTRSFIAALVIVGTVAMSLGASFGLSVLVWQHLLGIQINWVVLAMSVIVLLAVGSDYNLLLVSRMKEEIGAGLNTGIIRAMGGTGKVVTAAGLVFAATMASMIVSDLLTIGQVGTTIGLGLLFDTLVVRAFMTPSIAALLGRWFWWPQRVRQRPASAMLRSVGPRPLVRSLLLRD	MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH	24.26	gnl|BL_ORD_ID|2018|hsp_num:0	2208			2430	2820	erythromycin; acriflavine; tetracycline; chloramphenicol
BGC0000365.1|Glycopeptidolipid_2 # 981 # 3740 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.622	BGC0000365.1|Glycopeptidolipid_2 	981	3740	+	Loose	2070	38.891	smeE	25.18	3003056	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGCACATGGGGCAGAAGTTCGAGGAGTCCGACTCGGACAGCTTCGCCATGATCGTGCTGGAAGGGCAGGAACCCCTCGGCCCGGACGCACTCGACTACTACACCGGCCTGATAAGCGAACTGCGCAACGACTCGAAACATGTTGAGCACGTTCAGGATCTGTGGGGTGACCGGCTCACTGCGTCGAGCGCGCAGAGCGCCGACGGCAAGGCTGCCTACGTCCAGTTGAACCTCGCGGGTAATCAGGGCACGCCGTTGGGCGACGAGTCGGTTGCCGCGGTCCGTGATCTCGTCGCGCGAACTCCTGCGCCGGAGGGTGTCAGCGTGTACGTGACGGGCGCGGCGCCGCTAGTATCCGACATGCAGCACAGCGGTAACCGTTCGATCCTGAAGATCACCGCGGTCACCGTCGTCATCATCTTCGCGATGCTGCTGATGGTCTACAGGTCGGTCATCACCGTGATCCTGCTGCTGATCATGGTGGGCTTCGAAGTCGCAGCGGCTCGCGGCATCGTGGCATTCCTCGGCGCCAACGAGGTTTTCGTGCTGTCCACGTTCGCCGTGAACATGCTCGTCTTCCTTGCGATCGCGGCAGGCACTGACTACGGCATCTTCTTCTTCGGTCGATATCAAGAGGCGCGAGCGGCCGGCGAGGACCGCGAGACCGCCTACTACAGCATGTACCGCGGCGTCACCCCGGTCGTGATGGCGTCGGGTCTGACAATCGCCGGCGCGATCTTCTGTCTGACTTTCACACGCCTGCCGTACTTCCACACCATGGGTGTCCCGTGTGCGATCGGGATGCTCGCGGCCGTCGCGGTCGCGGTGACCCTGGTTCCGGCCGGTGTCGCTCTGGCAGGCCGAATCGGCTGGCTGGAACCGAAAAGGAAGATGCGAGTTCGCCGATGGCGCGGCATCGGCACCGCGATCGTGCGCTGGCCGGCCCCCATTCTCGTCGCATCGTTGGCTGTCGCACTGGTCGGACTGTTGGCATTGCCTGGCTACGAAACGAGCTACAACGACCGGGACTACATCCCGGCGGACATCCCGGCGAATGCCGGATTTGCCGCTGCCGACCGGCATTTCTCGCAAGCGCGGATGACACCCGACATCCTCATGGTCGAATCCGACCATGACATGCGAAATCCCACAGATTTTCTGGTCCTGAACAAGATCGCGAAAGCCATCTTCAAGGTTCGCGGCGTCTCCCGCGTACAGGGGATAACCCGCCCGGAGGGGACGCCGATCGAGCGTACGTCGATCCCATTTCTGCTGAGCCTGCAGAGTGCGGGACAGGTGCAGGCGACGAACTTCCAGAAGCAGCGCATCGGAGACATGCTCAAGCAGGTCGACGACATGAACATGATGATCGGCGTCATGAAGACGACCTATGGCGTCTTGCAGGAGCTCGCTGCCACGACCCATTCTCTGAACGGGTCGACACATGAATTACGGGATGTCGCCAGGGATCTGCGCGGCAGCATCGCGATCTTCGACGATCTTCTCCGTCCCATCCGGAACTATTTCTACTGGGAACCTCACTGCTATAACATCCCGATCTGCTGGTCGCTGCGCTCCATTTTCGATGCCATGGACGGGGTCGACCGGTTGAACGACGAACTGCAGGTGCTCGTCGACAACATGGATCGGCTGGACGCCCTGGTGCCGGAACTGGTGGCGCAGTTCCCGGAGTACATCGCCAGCATGGAAACGTTCCGGGAGCTGACCCTCACCTCGTACAGCACGTTCTCCGGTTTGCTCCAGCAGATGGACGAGCAAACAGAGGATGTCACCGCCATGGGACAGGCATTTGACGCCGCCAAGAACGACGACACCTTCTTCCTGCCTCCAGAGGTCTTCGACAACCCGGACTTCAAGCGCGCGATGACTTCTTTCCTGTCACCCGACGGAAAGGCTGCTCGCTTCATCATTTCGCACAACGGTGACCCCGCGACGCCGGAGGGCATCAGCCGCGTCGACCAGATGCAGACCGCCGCGGTAGAGGCCCTCAAGGGCACGCCTCTGACAGACGCGCAGGTGTACTTGGCGGGGACCGCGCCGACGGCGAAGGACTGGAAAGACGGTTCCACCTACGATCTCCTGATCGCGGGCATCGCCGCGATGTGCCTGATCTTCATCATCATGTTGATCGTCACGCGAAGCTTCATCGCGGCCTTGGTCATCGTGGGCACCGTCGTGCTCTCCCTGGGGGCATCATTCGGGCTGTCGGTGCTGCTGTGGCAGTACATCCTGGGAATCCATCTGCACTGGATGGTTCTCGCGATGTCGGTCATCATCCTGTTGGCCGTCGGCTCGGATTACAACCTGCTACTGGTGTCACGCATCAAAGAAGAAGTGGGAGCCGGCATCAACACCGGCATCGTCCGCGCCATGGGTGGTACGGGCAAGGTGGTGACGTCGGCCGGCCTGGTGTTCGCGGGCACAATGGCGGCGATGGTGGTCAGCGATCTGCGGATCATCGGACAGATCGGTACCACGATCGGTTTGGGGCTGCTGTTCGACACCATGATCGTGCGGTCGTTCATGACACCTTCGATCGCCGCGCTCCTGGGCCGGTGGTTCTGGTGGCCGCAGAAGGTGCGGCCGCGTCCTGCAAGTGCGCTCCTGGAGCCCTATGGGCCGCGACCGCTGGTGCGCGCATTGCTCGAAGGTCCGTCGGGTGCAGCGAGCCCCGGTGGTCCGGGAGGGCGACTGTCCGACGACGACACGCCGACCGGTCCGATGCGCACCCGATGA	MKHMGQKFEESDSDSFAMIVLEGQEPLGPDALDYYTGLISELRNDSKHVEHVQDLWGDRLTASSAQSADGKAAYVQLNLAGNQGTPLGDESVAAVRDLVARTPAPEGVSVYVTGAAPLVSDMQHSGNRSILKITAVTVVIIFAMLLMVYRSVITVILLLIMVGFEVAAARGIVAFLGANEVFVLSTFAVNMLVFLAIAAGTDYGIFFFGRYQEARAAGEDRETAYYSMYRGVTPVVMASGLTIAGAIFCLTFTRLPYFHTMGVPCAIGMLAAVAVAVTLVPAGVALAGRIGWLEPKRKMRVRRWRGIGTAIVRWPAPILVASLAVALVGLLALPGYETSYNDRDYIPADIPANAGFAAADRHFSQARMTPDILMVESDHDMRNPTDFLVLNKIAKAIFKVRGVSRVQGITRPEGTPIERTSIPFLLSLQSAGQVQATNFQKQRIGDMLKQVDDMNMMIGVMKTTYGVLQELAATTHSLNGSTHELRDVARDLRGSIAIFDDLLRPIRNYFYWEPHCYNIPICWSLRSIFDAMDGVDRLNDELQVLVDNMDRLDALVPELVAQFPEYIASMETFRELTLTSYSTFSGLLQQMDEQTEDVTAMGQAFDAAKNDDTFFLPPEVFDNPDFKRAMTSFLSPDGKAARFIISHNGDPATPEGISRVDQMQTAAVEALKGTPLTDAQVYLAGTAPTAKDWKDGSTYDLLIAGIAAMCLIFIIMLIVTRSFIAALVIVGTVVLSLGASFGLSVLLWQYILGIHLHWMVLAMSVIILLAVGSDYNLLLVSRIKEEVGAGINTGIVRAMGGTGKVVTSAGLVFAGTMAAMVVSDLRIIGQIGTTIGLGLLFDTMIVRSFMTPSIAALLGRWFWWPQKVRPRPASALLEPYGPRPLVRALLEGPSGAASPGGPGGRLSDDDTPTGPMRTR	MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDSVTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQEVQRQGINVAKSSSGFLNAIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGGKYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRLQTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANALDTAAGVDAALEDMKGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMALSVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIHRPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALENHFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQIKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRPNGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQAFRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASGDAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVPTAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGASLIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGVFFVPLFFVVVQRVFKRRSTT	88.37	gnl|BL_ORD_ID|807|hsp_num:0	876			678	1488	tetracycline; chloramphenicol
BGC0000365.1|Glycopeptidolipid_4 # 4333 # 5199 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.607	BGC0000365.1|Glycopeptidolipid_4 	4333	5199	-	Loose	1800	26.1794	mdtC	42.11	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCGGCATCATCCTCGCCGGCGGATCCGGTACCAGGCTGCACCCCCTCACCATCGGCGTCAGCAAGCAATTGCTCCCGGTGTACGACAAGCCGCTCGTCTACTACCCGCTGTCCACGCTGATCATGGCCGGCATCCGGGACATTCTGGTGATCACCACCCCCGCTGACGCACCGGCTTTTCGAAGACTCCTCGGCGACGGCTCGGATTTCGGTGTCAACCTCAGCTACGCCGCACAGAATGAGCCCGAAGGCCTTGCCCAGGCATTTCTGATCGGCGCCGATCACATCGGCAACGACACGGTCGCACTTGCCCTGGGGGACAACATCTTCTACGGACCAGGATTGGGCACGAGCCTGCGTCGCTTCGAACACGTCAGTGGTGGGGCAATATTCGCGTACTGGGTGGCAAATCCGTCCGCTTACGGTGTGGTCGAGTTCGATGCCGACGGGAAAGCGGTATCGCTGGAGGAGAAGCCCAAGACGCCGAAATCCCATTACGCCGTGCCCGGCCTCTACTTCTATGACAACACCGTCATCGACATCGCACGATCGCTGAAGAAATCAGCTCGCGGAGAATACGAGATCACCGAGGTCAACCAGATCTACCTGAACCGCGGCCAATTGTCCGTGGAGGTGCTGGCTCGCGGGACCGCTTGGCTCGATACCGGCACGTTCGATTCGTTGTTGGATGCCAGCGATTTCGTCCGGACGATCGAACTGCGTCAGGGCCTGAAAGTCGGCGCACCCGAGGAGATCGCGTGGCGCGCGGGATTCATCGATGACGATCAACTCGCGACACGCGCCAAGGAACTGCTGAAGTCGGGCTACGGCCACTACCTGCTCCAACTTCTGGATCGAGAGTAG	MRGIILAGGSGTRLHPLTIGVSKQLLPVYDKPLVYYPLSTLIMAGIRDILVITTPADAPAFRRLLGDGSDFGVNLSYAAQNEPEGLAQAFLIGADHIGNDTVALALGDNIFYGPGLGTSLRRFEHVSGGAIFAYWVANPSAYGVVEFDADGKAVSLEEKPKTPKSHYAVPGLYFYDNTVIDIARSLKKSARGEYEITEVNQIYLNRGQLSVEVLARGTAWLDTGTFDSLLDASDFVRTIELRQGLKVGAPEEIAWRAGFIDDDQLATRAKELLKSGYGHYLLQLLDRE	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	28.10	gnl|BL_ORD_ID|1212|hsp_num:0	1315			2901	3015	novobiocin
BGC0000365.1|Glycopeptidolipid_6 # 5718 # 6974 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.639	BGC0000365.1|Glycopeptidolipid_6 	5718	6974	+	Loose	600	80.4925	rgt1438	26.96	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGGCGAGTTATGGCACCCGCGGTGATGTCGAACCGGCTGTTGCGGTGGCTCGTGAGCTACGCAGACGAGGCCATGATGTGTGCATCGCCGTCCCACCTGACCTCGTGCGGTTCGCCGAGGACGCCGGGCTCTCGGCCACTTCGTACGGCATGGAGGTCGAGCCGCAGTTGGACGCGTACCGCGACATATGGACTTCGTGGGCACGTAAACTCTGGCGCCTGCAGGATTTCGTGAACCTCTGCAGAGAGGCACTGGGCGTGACGATCTCTCAGTGGGAGGACATCGGCAAGACTCTGGTGACGCTCGCCGACGGGGCAGACCTGCTCACGACCGGGGTAGGTTTCGAGCAGCCTGCCGCCAACGTCGCGGAGTATTACGGTATTCCGCTGATTGCGCTGCACACGTTCCCTTGGCGTCCGAACGGCCGACTTGTTCCGGCAATACCACCTTTACTCACACGCTCGGCTATGAACGTCTACGACTGGCTGGGCTGGCGCCTGACGAAGCAAGCCGAGGACGCACAGCGGCGCGAGTTGGGCTTGCCGATGGCGACTAGTGCCGCCCGGCAGCGGATGGCGGAACGGGGCGTTCTGGAGATCCAGGCCTATGACGCGATCTCCTTCCCCGGTCTCGCCGACGAGTGGGCACGGTATGGCGCCAGACGACCCTTCGTCGGCACTCTGACGATGGAGTTGGCGACCGCGGACGACAGTGAGGTCACGTCGTGGATCGCGCACGGAACGCCGCCGATCTGCTTCGGATTTGGCAGTATCCCGGTCGAATCTCCCGCCGAGACAATCGACATGATCGCGTCGGCATGCGCGGAGTTGGGTGAGCGGGCGCTGGTGTGTGCCGGCGGGACGGACTTCGGTGATTCACCCAGGTTCGAGCACGTGAAGGTCGCGGGAACCGTCAACTATGCGACGGTGTTCCCGGTCTGCCGTGCTGTGGTCCATCACGGCGGCTCGGGAACGACAGCGGCGAGCCTTCGTGCCGGAGTGCCCACGTTGACTCTGTGGACAGCTGGTGATCAGCCGTTCTGGGGCGCGCAGCTGAAGAAGTTGAAAGTAGGTGCATCGCGCCGTTTCTCGGCCACGACGCGCGATACCCTCGTGTCGGACCTGCGCCGGATCCTCTCTCCCGAATATGCCGTCAAGGCGCGTGAGGTCGCCACCCGGATGACGAATCCGGCTGAAAGTGTCAGCCGAGCAGCCGATCTCATCGAACAGAACCTCGATCCCACACGCCGCTCGTGA	MASYGTRGDVEPAVAVARELRRRGHDVCIAVPPDLVRFAEDAGLSATSYGMEVEPQLDAYRDIWTSWARKLWRLQDFVNLCREALGVTISQWEDIGKTLVTLADGADLLTTGVGFEQPAANVAEYYGIPLIALHTFPWRPNGRLVPAIPPLLTRSAMNVYDWLGWRLTKQAEDAQRRELGLPMATSAARQRMAERGVLEIQAYDAISFPGLADEWARYGARRPFVGTLTMELATADDSEVTSWIAHGTPPICFGFGSIPVESPAETIDMIASACAELGERALVCAGGTDFGDSPRFEHVKVAGTVNYATVFPVCRAVVHHGGSGTTAASLRAGVPTLTLWTAGDQPFWGAQLKKLKVGASRRFSATTRDTLVSDLRRILSPEYAVKAREVATRMTNPAESVSRAADLIEQNLDPTRRS	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	101.70	gnl|BL_ORD_ID|116|hsp_num:0	134			12	1209	rifampin; rifaximin; rifabutin; rifapentine
BGC0000365.1|Glycopeptidolipid_7 # 7092 # 8165 # 1 # ID=1_7;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.635	BGC0000365.1|Glycopeptidolipid_7 	7092	8165	+	Loose	1200	32.3426	arnA	54.84	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	TTGTCCAACACCGTTCTCATCACCGGCGGGGCGGGATTCATCGGGTCCGCACTTGCCCAGCGACTTACGCATGAGGGGTATGAGGTCGCAGTGATGGATCTACTCCACCCCCAGGTTCACGCGAGGGGAAGCAAAGTCGACCTGCCGCGCTCCGTACGGCTCTTCACCGGCGACGTGACGCACGCTCCCGACTGGGACGCTGTCCTCAGGTTGTTCCAGCCTGCTCAGGTTGTGCATCTGGCGGCCGAGACCGGCACCGCACAGTCACTGAGCGAAGCGACACGTCACAGCTCGGTCAATGTGGTGGGTACAACGCAACTCCTCGATGCTCTCAGCCGGGCGGATCTCGTGCCCGACCAGATCGTTCTGGCGTCGTCACGAGCCGTCTACGGTGAGGGCGAATGGCGTACCGCCACCGACTCCACCTTCTACCCTCTGCCACGCAGTCACGCTCAGTTGGCAGCAGGCCGGTGGGACCCGGTGGGGCCCAACGGCGAACACGCGGTCCCGCTTCCGAGTTGCGCGAGCCGCACCGAGCCCCGTCCGACGAATGTCTACGCCGCGACGAAACTTGCCCAAGAACATGTGCTCACCGCATGGACCGCCGCGCATGACACGAAGTTGAGCGTGCTGCGTCTGCAGAATGTCTACGGCCCCGGGCAGTCGCTGACCAACTCCTACACCGGGATTGTTGCGCTGTTCGCCCGACTTGCACGCGAGCAACAGACGTTGGAGGTTTACGAAGACGGAAATATACTGCGGGACTTCGTGTTCATCGAAGACGTCGTCGAGGCGTTGTATGCCGCGATTCGCCGGCCTGCTGATCAGCGACGCTGCCTTGACATAGGTTCCGGCGTCGGATCGAGCATCCACGCTCTGGCGCAGAAGGTAGCGGGGATCTGCGGCGCTCCCACCCCGAAGGTGGTGGGCAAATTCCGAGACGGCGACGTGCGCGCGGCGAGCTGTGACATCGAGCCGGCCCGGATGGAACTGGACTGGCGGCCCAAGTGGACGCTCGACGACGGTCTGCCTGCCCTGCTCGACTGGATAGCAAAGTCTGACGTTTCACACTGA	MSNTVLITGGAGFIGSALAQRLTHEGYEVAVMDLLHPQVHARGSKVDLPRSVRLFTGDVTHAPDWDAVLRLFQPAQVVHLAAETGTAQSLSEATRHSSVNVVGTTQLLDALSRADLVPDQIVLASSRAVYGEGEWRTATDSTFYPLPRSHAQLAAGRWDPVGPNGEHAVPLPSCASRTEPRPTNVYAATKLAQEHVLTAWTAAHDTKLSVLRLQNVYGPGQSLTNSYTGIVALFARLAREQQTLEVYEDGNILRDFVFIEDVVEALYAAIRRPADQRRCLDIGSGVGSSIHALAQKVAGICGAPTPKVVGKFRDGDVRAASCDIEPARMELDWRPKWTLDDGLPALLDWIAKSDVSH	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	53.93	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1050	polymyxin B
BGC0000365.1|Glycopeptidolipid_8 # 8240 # 9148 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.602	BGC0000365.1|Glycopeptidolipid_8 	8240	9148	+	Loose	700	27.335	CMY-98	32.43	3002111	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGGGGTGGGCTCGGTCGTCAGTAAGCTGGGCCTCATGGCATTTCGCGAACCTCAACGTCGCCCTTTTTTCTGCGAAGAGCAAAGGATCTCGTGACGTGCTCGCTTTCCGCTTGGTGATACAGCCGAGGTTCCCGTTCGTCGCACGCCGGTACGCGTACACAGGCCGCCAGAAGATGCTCCAGGCGCTCGGGCCCGATCTGTCCCGTTCGGTCACCATGACTGCCGACGACTCGGTACCTGAGGAAACCTCGATCGGACGGATATTCGAAGGTACCCACGACGTCCACAAGCTCCGCCACTACCTGCCGATCTATGAGCGGGTCCTCACCAACGCGGGCAAGATGCTGGAGATCGGTGTGGACCGTGGCGGGTCACTGGAGATGTGGCGACAGTATCTGCCCGAGACAACCATCGTCGGAGTCGACATCAATCCCAGGGCGGCGCAGTACGACGATCCTGACCGGCGTATCCACGTGCGCATCGGCGATCAGACCAACACCCACTTCCTGCAGGCGGTTCTCGACGAGTTTGGTGCCTTCGACACGGTGCTGGACGACGGTGGGCACACTCCGAAGCAGATGATCAGTTCGTTTCAGTATCTGTTCCCCCGGCTCAAGGCCGGTGGTGTGTACGTTGTCGAGGACGTCTGCGCCAACTATTGGACGAGCTACCGTGACCAACCCGAGTCGTTCATCGATTTCACCAGGTGGCTCATGGACGCGATGCACGCGCCCTACATGCGCATGAACTCCGTGTTCCAGATCATGGAGGGGCACCAGAAGCGCCTGCGCCATGTCGAGGTGCCCTATGCAGCAACTATCATCGACAGGATCGAAGTCTTCGACTCGGTGGTGGTGATCCATCGTGCGGACGAGTCCAAGCGGTTACCTCGGGCGGCGTACCAGTAG	MGWARSSVSWASWHFANLNVALFSAKSKGSRDVLAFRLVIQPRFPFVARRYAYTGRQKMLQALGPDLSRSVTMTADDSVPEETSIGRIFEGTHDVHKLRHYLPIYERVLTNAGKMLEIGVDRGGSLEMWRQYLPETTIVGVDINPRAAQYDDPDRRIHVRIGDQTNTHFLQAVLDEFGAFDTVLDDGGHTPKQMISSFQYLFPRLKAGGVYVVEDVCANYWTSYRDQPESFIDFTRWLMDAMHAPYMRMNSVFQIMEGHQKRLRHVEVPYAATIIDRIEVFDSVVVIHRADESKRLPRAAYQ	MAAQSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYYFTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQWQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMGYEEAMTKRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSLVDMTRWIQANMDASQVQEKTLRQGIEIAQARYWHIGDMYQGLGWEMLNWPVNADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRI	80.32	gnl|BL_ORD_ID|268|hsp_num:0	297			735	846	
BGC0000365.1|Glycopeptidolipid_9 # 9439 # 10200 # 1 # ID=1_9;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.631	BGC0000365.1|Glycopeptidolipid_9 	9439	10200	+	Loose	550	25.0238	TER-2	29.63	3007007	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	TER beta-lactamase	TTGCGTAGAGACCTGACCCGATACGGGAGCGACGAACTCGTGCCCGTCGGGTGGGACTGGTTCCACCGTCCCCTCTTCAAGATCGGCAACCTGATGCTCGTGCGGAGACGTCCGTTCGATCCGCGCAAACGCGATCTGGGACTGGACTGGCCGGCTGACGCATTGACGATGATCGGGATGACCAGGCTGACGAGCCTTCAACAATGTGTCGAGACCGTCATCACCGAGGATGTCCCCGGCGACCTCGTGGAGTGCGGCGTGTGGCGCGGTGGGGCCTCGATCCTGATGCGCGCAGTTCTGAGCGCCTATGGTGACGAATCGCGCCGAGTGTGGCTCTGCGATTCCTTCGCCGGGGTGCCTGCGCCGGACGCAGCGAAGTACAAAGCCGACAAGGGCGACCGACTGCACCTGGCCGCTCCGATTCTCGCAGTTTCCGAACAGGACGTTCGGGCGAACTTCCAGCGGTACGGCTTGCTGGACGATCAGGTCCGTTTCGTGCCCGGCTGGTTCAAGGACACGCTGCACGACGCTCCGATCGAACGCATCTCGATCCTTCGACTCGACGGCGACCTGTACGAATCCACCATCCAGGCGCTCGACGGGCTGTACGAGCGGTTGTCACCCGGGGGCTTCTGCATCGTCGACGACTACCACGCGATCGACGGATGCCGTCAAGCCGTCACGGATTACCGTGCCAAGCACGGGATCTCCGCAGAAATCGTCGAGATCGACGGTACCGGTGTGCTCTGGCGCAAGGAGTGA	MRRDLTRYGSDELVPVGWDWFHRPLFKIGNLMLVRRRPFDPRKRDLGLDWPADALTMIGMTRLTSLQQCVETVITEDVPGDLVECGVWRGGASILMRAVLSAYGDESRRVWLCDSFAGVPAPDAAKYKADKGDRLHLAAPILAVSEQDVRANFQRYGLLDDQVRFVPGWFKDTLHDAPIERISILRLDGDLYESTIQALDGLYERLSPGGFCIVDDYHAIDGCRQAVTDYRAKHGISAEIVEIDGTGVLWRKE	MRHSLFAPILLLALFALPAWAHEATVNQVKAAERQLEARVGYAELDLASGRLLASYRPDERFPMMSTFKVPLCAAVLARVDAGEEKLDRRVRYRQQDLVEYSPVTEKHLADGMTVAELCAAAITLSDNTAANLLLASVGGPQGLTAFLRRSGDQTSRLDRWETELNEALPGDARDTTTPQAMAKTLRNLLTGSVLSAASRQQLRSWMVDDKVAGPLLRSALPHGWFIADKTGAGNRGSRGIIAALGPDGQPARIVIIYLTGTEASMDERNRQIAEIGETLVKHW	89.08	gnl|BL_ORD_ID|4600|hsp_num:0	5671			483	645	
BGC0000365.1|Glycopeptidolipid_10 # 10234 # 11502 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.628	BGC0000365.1|Glycopeptidolipid_10 	10234	11502	+	Loose	600	74.7146	rgt1438	26.68	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGAAATTTGTGCTGGCGAGTTACGGGACGCGAGGCGACATCGAACCTTCCGTCGTTGTCGGTCGCGAACTGCAGAGCCGGGGCCATACCGTCCTGATGGCTGTGCCGCCTGACCTGATCGAGTTCACGGAGGCCGCGAACTTGAGGACCGTGGCCTACGGCCTGGACACGAAAACGTGGCTGGATATCTACCGCAACTTCTGGACCTTCGCCCTGCACAGATTCTGGAAGGCCCGGGAAATTCGGTCGTTGTGGCGTGAGATGTGGGACCTCAGTGACGAATGCTGGGCACAGATGAACGCCACTCTCAGGTCGGTGGCTGCCGATGCGGACGTCTTGTTCGCCGGACAGAGTTATCAAGAGCCTGCCGCGAATGTGGCGGAATTCTACGATGTTCCACTCGTCACGCTGCACCACATCCCGATGCGACCCAACGGCCGGCTTGTCACGTTCCTGCCGCCGGTACTGGCGCGCGCATCGATGACCGCGTTCGATTGGTTCGCTTGGCGGTTGAACAAGAAAGTCGAGGACGCGCAGCGGCGCGACCTCGGACTTCCGAAAGCGACTGGCCCGTCGACACAACGGATCGCCGACCGGATGTCTCTGGAAGTTCAGGCATACGACGAGGTCTGCTTTCCAGGGCTGGCGGAGGAATGGGCGAAATGGGGGGAGCTGCGTCCATACGTGGGCACCCTCACGATGGAACTCACCACCCCGGCGGATGAAGAAGTGTCGTCGTGGATATGCGGCGGCACGCCTCCGATCTGCTTCGGCTTCGGCAGCATGCCGGTGGAATCGCCGGCTGACACTGTGGCGATGATCAGCTCAGTTTGTGCAGAGCTGGGCGAGCGAGCGCTGATCTGTGCCGGCTGGAGCGACTTCAGCGACGTCGCGCTCGCCGATCACGTGAAGGTCGTCGGCGCAGTCAACTACGCCACCGTGTTCCCGGGTTGCCGCGCAGTTGTGCATCACGGGGGTTCCGGGACCACCGCGGCCAGCCTCCGCGCCGGGCTGCCCACGCTGGTCCTGTCGATGGATGCCAACCAGGCTCTCTGGGGTGCCCAGATCAAGCGTTTGAAAGTCGGTACCACGCGGCGGTTCTCGAAGACGAATCGGCGGACGCTGATCGCCGACTTGCGTACGATTCTCGATCCGGCGTATGCGGCTCGCGCTCAAGCTCTCGCACGAGGAATGACCAGACCGGCCGAGAGTGTCGTCAGAGCGGCCGATGTCATCGAGGCCTTCGCGAGGTCGAGGTGTTCGGCGTGA	MKFVLASYGTRGDIEPSVVVGRELQSRGHTVLMAVPPDLIEFTEAANLRTVAYGLDTKTWLDIYRNFWTFALHRFWKAREIRSLWREMWDLSDECWAQMNATLRSVAADADVLFAGQSYQEPAANVAEFYDVPLVTLHHIPMRPNGRLVTFLPPVLARASMTAFDWFAWRLNKKVEDAQRRDLGLPKATGPSTQRIADRMSLEVQAYDEVCFPGLAEEWAKWGELRPYVGTLTMELTTPADEEVSSWICGGTPPICFGFGSMPVESPADTVAMISSVCAELGERALICAGWSDFSDVALADHVKVVGAVNYATVFPGCRAVVHHGGSGTTAASLRAGLPTLVLSMDANQALWGAQIKRLKVGTTRRFSKTNRRTLIADLRTILDPAYAARAQALARGMTRPAESVVRAADVIEAFARSRCSA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	102.68	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1149	rifampin; rifaximin; rifabutin; rifapentine
BGC0000365.1|Glycopeptidolipid_11 # 11709 # 12791 # 1 # ID=1_11;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.584	BGC0000365.1|Glycopeptidolipid_11 	11709	12791	+	Loose	700	26.9498	tap	37.78	3000343	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGGGCAAGGTGTTCGACCCGCGAAACAACGCACTGAATGCCCTGCGCCTGTTACTCGCGGTCGGTGTCATATTGTGGCACTCGTGGCCGCTGAGCGGCCACGGCGTGACCTACAAGCCACTCGAGCAGCTGCTCGAACAGGTTTGGGTTGATGGGTTTTTCGCCATATCAGGATTTCTCATCACCTCAAGCTGGCTTCGAAACCCACGACTGCGTGATTATGCGACGGCCCGTGTCTTGCGCATCTTCCCGGGATTGTGGGTATGTCTGCTGATAATCGCCTTCGTCATGGCGCCTATCGGTGTACTACTCCAGGGCGGTTCTGTTTCCGGTCTGATGTCGTCATACGCACCGATCGAATATGTGCTCAACAATGCCGTTCTGAACGTGTACTACGCGGGAATCAACGGCACACCGCAAGGCATTCCGTGGCCCGGTGTCTGGAACGGCTCGCTCTGGACGCTCGTCTTCGAGATGATTTGTTACATAGCGGTGGCAGTGCTCGGCATCGTCGGCTTGCTGAAGCGGCGGTGGGTCATCCCGGCGATCTTCGTTCTCACACTCTGTGCCACGGCGTACTTCTCGTACCCGGTCTTCGCGATGCAAACGATTCCGCAGATGGTTGCGCGATTCGCCGTAATGTTCGCGGCCGGCGCGTTGATACACCAGTACCGTGACGTCATCCCGGCGCGCTGGTCGCTCGTCGGCATCGCGGTGGTGCTCGTTCTTGCGTCCGGTTTTCTTTCGAATTATCGCGTGATCGGCGCCCTCCCTTTGGCGTACGCCGTCATCGTGGCTGGTGCGCTACTACGCAACCGACGACTGAATCTGCGCAACGATCTCTCGTACGGTGTCTATATCTACGCGTTTCCGGTGCAGCAGCTCCTGGCGATTCTCGGTTTTGCAAATTCCCAGCCGTTCTTGTTCTTTGTCATCGCGACGGCCGCCACAGTTCCCCTGGCAGCGCTCAGTTGGTTCTTGGTGGAAAAACGTGCAATTGCGCTGAAGTCCCGTCTGAAGCGGCGTCGCACAGACACTGTCGCGGACACCACCCAGAAGGTCTCGGACCGTGGTGCCGGTTAG	MGKVFDPRNNALNALRLLLAVGVILWHSWPLSGHGVTYKPLEQLLEQVWVDGFFAISGFLITSSWLRNPRLRDYATARVLRIFPGLWVCLLIIAFVMAPIGVLLQGGSVSGLMSSYAPIEYVLNNAVLNVYYAGINGTPQGIPWPGVWNGSLWTLVFEMICYIAVAVLGIVGLLKRRWVIPAIFVLTLCATAYFSYPVFAMQTIPQMVARFAVMFAAGALIHQYRDVIPARWSLVGIAVVLVLASGFLSNYRVIGALPLAYAVIVAGALLRNRRLNLRNDLSYGVYIYAFPVQQLLAILGFANSQPFLFFVIATAATVPLAALSWFLVEKRAIALKSRLKRRRTDTVADTTQKVSDRGAG	MTNTKRGPLLLILFAALTAGAGNGITIVAFPWLVLQHNGSALDASIVAMAGTLPLLVATLIAGAAVDYLGRRRVSMISDLLSALSVAAVPVLALIFGVDAVNVAVLAVLAGLGAFFDPAGMTARETMLPEAAGRAGWTLDHANSVYEAVFNLGYIVGPGIGGLMIATLGGINTMWVTAGAFCCSILAISVLRLEGAGAPDRSVLTEAVLAGIVEGLRFVWYTPVLRTLAIVDLVATGLYMPMESVLFPKYFTDRNEPTELGWVLMALSIGGLLGALGYAVMSRYMSRRATMLTAVITLGVAMTVIAFLPPLPLILVLCAIVGFVYGPIAPIYNYVMQTTAPQHLRGRVVGVMGSLAYAAGPLGLILAGPLADAAGLHATFLALSLPMLLLGVVAVFLPRLRELDLASKP	88.02	gnl|BL_ORD_ID|1577|hsp_num:0	1720			150	285	tetracycline
BGC0000365.1|Glycopeptidolipid_12 # 12953 # 13753 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.612	BGC0000365.1|Glycopeptidolipid_12 	12953	13753	+	Loose	575	24.6386	ELM-1	41.38	3006885	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ELM beta-lactamase	ATGGTTGGCGCTGTGGCAAATGGACTTTCGGTCCGCGCTCGTCTGCTGACCCAGGCTGTGCGCGCGGAGTACTGGCTCGCGCGCAAGTTGTTGCCCGACGTCTACTCCAACGATGCGTTGATCTGTTTCAACAGCCACGCTTTCATGGATGACCCTGACTTCCAGCGGGCGTACCGGCGCGGCGCACGCGCCCTCGGAGACAACGACTGGTATCAGTGGCATTGGCGGGTGCACGTCGGTTTGTGGGCAGCCGCCAGCGCCAGCAAGATCGACGGCGCTTTTGTCGAGTGCGGCGTGAGCTACGGCTTCCTGAGCAGCGCCATAATGGAGTACCTCGACTGGGACAAGCTGGGGAAGACGTTCTATCTCCTCGACACGTTCGCGGGCCTCGATCCCCGGTATGTCACCGAGGCCGAACGTGCGTCGGGGGCGCTGGAACGCAGCGAAGAGCATCTCCGTAACGGTTTCTACGTGGACTCAGTGGACAGCGTGCGAGCAAACTTCGCGCAATGGAAGAATCAGCGCATCATCGTCGGTGCGGTTCCGGAGACGCTCGCCGAAGTCGACGCAGAAGCCGTGGCTTTCTTGCACATCGACATGAATTGTGCGCCGCCTGAGGTCGCCACTTTGCGATACTTCTGGCCGCGCTTGTCCCCTGGGGCATTCGTGCTTCTCGACGACTATGCCAATCGCGGTCGTGACGAGCAACGAGTGGCGATGGACGAGGTTGCGAGCGAACTAGGTGTGCAGATTTGCACTTTGCCCACCGGTCAGGGCCTTCTCATCAAGCCACCGCTGTAG	MVGAVANGLSVRARLLTQAVRAEYWLARKLLPDVYSNDALICFNSHAFMDDPDFQRAYRRGARALGDNDWYQWHWRVHVGLWAAASASKIDGAFVECGVSYGFLSSAIMEYLDWDKLGKTFYLLDTFAGLDPRYVTEAERASGALERSEEHLRNGFYVDSVDSVRANFAQWKNQRIIVGAVPETLAEVDAEAVAFLHIDMNCAPPEVATLRYFWPRLSPGAFVLLDDYANRGRDEQRVAMDEVASELGVQICTLPTGQGLLIKPPL	MPMEQALFVRIARALAASLITLSAVAFAQEPKVDIPADQQAFVDICKPWDEWDKPAPPFEIYRDTYYVGTCGIAAILITDEEGHILIDSGTEAGADVVMANVAALGFDLKDVRYLLYSHEHFDHVGGMAKLQRATGALVVASKAAEPVLTSGEDSLADPQHGMHEPFEGVAVGRIMAAGDILELGGTTIRAIETPGHTPGAMSWWWQECKERCENIVYADSLSPISRDDYRFGDHPEYVAAYRAGLVALGREDCTVLLTPHPSHSRMIRRMQEGDLIENRQGTRPCARYAGQKLLDLETRLSNETLSEEDRAQ	84.98	gnl|BL_ORD_ID|3530|hsp_num:0	4599			672	759	
BGC0000365.1|Glycopeptidolipid_13 # 13791 # 14942 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.624	BGC0000365.1|Glycopeptidolipid_13 	13791	14942	-	Loose	600	62.3882	rgt1438	31.58	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	GTGCCCCCGGGTCTCGTCGCTTTCGCCGAAACGGCCGGACTAGATGCAGTGGCGTATGGGCCCGAGTTGGACAATTTTCTGCGCGACGATTTCCTTCGCAATTTCTGGATGCAGATGATCCGCAACCCTGTTGGCTCACTTCGCGAACTCTGGGCGCCCATAACCCGCTACTGGAACGATACGAGCAAGGTGCTCACAACGCTCGCAGACGGTGCCGATCTGCTGTCGACGGGAATAAATTTCGAGCAGGCAGCCGCGAACGTTGCCGAGCACTACGACATTCCGTTCGTCTCTCTGCATCACTTCCCCATGCGTCCCAACGGAAAGCTGGTTCCGGCTCTGCCGGCCTCGGTGGTCCGCTCCGTCGGCGCCCTCTCCGAGTGGTTGTTCTGGCGCTCGACGAAAGAGGTCGAGGATGCGCAACGGCGCGAACTCGGATTGCCACGGACGAAGGTTCCGTCCCCGCGGAGGATCGCCGAACGCGGGTCACTCGAGATTCAGGCCTATGACGCGGTGTCCGTACCTGGGCTGGCCGACGAATGGGCAGATCAAAACCGCCAGCGGCCGTTCACGGGCGCGCTCACGATGAGTTTGTCGACCGAAGCCGACGACGACGTCACATCGTGGATCACATCGGGCGAACCGCCGATCTGCTTTGCGACAGGCAGTATCCCTGTCCAGTCACCCACGGCCACGATCGAGATGATCAGTCACGCGTGTGACCAGCTGGGCCAGCGAGCACTGGTCTGTGCCGGCGGCACCGATCTTCGCGGTGTTCCGCAATTTGACAACGTCAAAATGGTGGGCGCGGTGAACTATGCGGCAGTGTTCCCATTGTGCCGCGGAATCGTCCATCACGGCGGCTCGGGTACGACGGCAGCAAGCCTTCGCGCCGGGGTACCCACCTTGATCCTCTGGAGCACAGCCGACCAACCGTATTGGGGCAACCAGCTCAAACGACTGAAGGTTGGGACCTCGCGCCGCTTTTCGGGCGCAAGTCGCAAATCACTTGTGACGGACCTGCGCCGGATTCTCCGACCCGAGTATGCGGTTCGGGCGCGCGAGCTCGCCATGCGGATGACCCCGGCCGCCGAGAGCGTGACCATCGCCGCCGATCTCTATGAAAACGCGGTGCGCCAAGCGGCGATGTGA	MPPGLVAFAETAGLDAVAYGPELDNFLRDDFLRNFWMQMIRNPVGSLRELWAPITRYWNDTSKVLTTLADGADLLSTGINFEQAAANVAEHYDIPFVSLHHFPMRPNGKLVPALPASVVRSVGALSEWLFWRSTKEVEDAQRRELGLPRTKVPSPRRIAERGSLEIQAYDAVSVPGLADEWADQNRQRPFTGALTMSLSTEADDDVTSWITSGEPPICFATGSIPVQSPTATIEMISHACDQLGQRALVCAGGTDLRGVPQFDNVKMVGAVNYAAVFPLCRGIVHHGGSGTTAASLRAGVPTLILWSTADQPYWGNQLKRLKVGTSRRFSGASRKSLVTDLRRILRPEYAVRARELAMRMTPAAESVTIAADLYENAVRQAAM	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	93.19	gnl|BL_ORD_ID|116|hsp_num:0	134			693	1149	rifampin; rifaximin; rifabutin; rifapentine
BGC0000365.1|Glycopeptidolipid_14 # 15247 # 16071 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.602	BGC0000365.1|Glycopeptidolipid_14 	15247	16071	+	Loose	550	41.5874	RlmA(II)	25.0	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGGCCCTCGGAAACGCGTTGGTGGAGGCCCGAGACCGCGTCGCGTGGAGGCTGAACATCAAAGTCGCGCAACAAGCGCAGAAGCTCGTCTACCGGTACGCGACCCGCAGGCTGAAAGACGACGACGTGGTCTTCCTCAATTACGGGTACGAGGAAGATCCGCCGATGGGCATACCGCTTTCGGAGTCCGACGAACTCAACCGCTACTCGATCCAGCTGTACCACAGCACGGCAGCCCAAGCCGATGTCGAGGGGAAGCGCGTACTGGAGGTCGGGTGTGGCCACGGCGGCGGCGCTTCGTACCTCGCACGCACTTTCCGTCCGGCCACCTATACTGGCTTGGACCTCAACTCGGACGGCATCAACTTTTGCCGAAGGCGGCACAATATCGCGGGTTTGGAGTTCGTACAGGGAGACGCTCAAGATCTGCCATTTCCCGACAAGAACTTCGACGCGGTCCTCAACGTCGAATCGTCACACCTCTATCCGCGGTTCGACGTGTTTCTGACAGAGGTCGCGCGGGTGCTACGCCCGGGCGGGTATTTTCTGTACACAGACGCACGTCCCCGCTACGACATTCCCGAATGGGAGCGGGCGCTCGCGGATGCGCCGTTGCAGATGCTTTCTCAGCGGGCGATCAACTTCGAGGTGGTACGGGGTATGGAAAAGAACCTCGATGCGCTCGAATCGGTGGTAGACCGCGTCGCCCCGGCACTCCTCCGAGATTGGATTCAGAAGTACGGTCCGGCCAGAAGGGCGTATGAAGAGCTTCGGGAGAACACGACCGAATATCGGATGTATTGCTTTGTGAAGCCGGCGGAGTGA	MALGNALVEARDRVAWRLNIKVAQQAQKLVYRYATRRLKDDDVVFLNYGYEEDPPMGIPLSESDELNRYSIQLYHSTAAQADVEGKRVLEVGCGHGGGASYLARTFRPATYTGLDLNSDGINFCRRRHNIAGLEFVQGDAQDLPFPDKNFDAVLNVESSHLYPRFDVFLTEVARVLRPGGYFLYTDARPRYDIPEWERALADAPLQMLSQRAINFEVVRGMEKNLDALESVVDRVAPALLRDWIQKYGPARRAYEELRENTTEYRMYCFVKPAE	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	97.16	gnl|BL_ORD_ID|2052|hsp_num:0	2274			294	561	tylosin; mycinamicin
BGC0000365.1|Glycopeptidolipid_15 # 15884 # 16486 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.592	BGC0000365.1|Glycopeptidolipid_15 	15884	16486	-	Loose	200	25.0238	vanH gene in vanO cluster	25.0	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGTTCAAATTCGATCGAAATTCACGGCGTGAAATTCGTCCTCGACCAGAGGTCTATTTTCCGTCGACGGCGGAGTCTTCAGCACTGACCTGCGTTCCCTCGATCGGAGAGGAACCGCGCGGCATCAGCATGAAGAACAGTGGCACTCGCACAACCGCCCCACCCGCGATCGGCATACGCACCGCGAAGGACACAACTTCCAACTCCAGTCGCTTTCCGCGTTGTGTCTCCATCTCCAGGCGACCTGGTAGCCGCTTGGGCGCCGCGAGCCAATCAAGCCCGCGTTCGATCGACTGCACCAGGTTCATGCCCTCACTATACCCACGGACGATCCTGCGCTCGCCAGCGTCAGGCACCGCGAACCGCGGTGTCGATCAACACCGTTGCGGTGCAGTGTTTCCCAGAAACCCGGAGCTCACTCCGCCGGCTTCACAAAGCAATACATCCGATATTCGGTCGTGTTCTCCCGAAGCTCTTCATACGCCCTTCTGGCCGGACCGTACTTCTGAATCCAATCTCGGAGGAGTGCCGGGGCGACGCGGTCTACCACCGATTCGAGCGCATCGAGGTTCTTTTCCATACCCCGTACCACCTCGAAGTTGA	MFKFDRNSRREIRPRPEVYFPSTAESSALTCVPSIGEEPRGISMKNSGTRTTAPPAIGIRTAKDTTSNSSRFPRCVSISRRPGSRLGAASQSSPRSIDCTRFMPSLYPRTILRSPASGTANRGVDQHRCGAVFPRNPELTPPASQSNTSDIRSCSPEALHTPFWPDRTSESNLGGVPGRRGLPPIRAHRGSFPYPVPPRS	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	57.14	gnl|BL_ORD_ID|761|hsp_num:0	786			123	255	vancomycin
BGC0000365.1|Glycopeptidolipid_16 # 17609 # 18730 # 1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.691	BGC0000365.1|Glycopeptidolipid_16 	17609	18730	+	Loose	500	29.261	CIA-1	31.25	3004768	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	CIA beta-lactamase	TTGGCTCATGAACCGTTCGGGTGGCGACCCACGGCTTTGCTGGTCACGATCCGCCGTTACCGTTGCGCCGGCTGCGCTCATGTGTGGCGCCAGGATGCCAGCGCCGCAGCCGAACCGCGGGCCAGGCTGTCCCGGCGTGCTCTGCGGTGGGCGCTGGAAGCCCTTGTCTGCCAACACCTGTCGGTGGCCCGGGTCGCCGAGGCGCTTGCGGTGTCGTGGAACACTGCCAACAACGCCGTGCTCGCCGAAGGTCAGCGGGTGCTCATCGCCGATCCGGCCCGGTTCGATGGCGTCGCGGTGATCGGCGTCGATGAGCACGTGTGGCGGCACACTCGCCGCGGCGACAAGTACGTCACCGTCATCATCGATCTCACGCCCGTGCGTGACGGGACCGGCCCCGCACGGCTGCTCGACATGGTGGAGGGCCGCTCCAAGAAGGCGTTCGCCGACTGGCTGGCACAGCGGCCACAGGAGTGGCGTGATCGTGTGGACGTTGTTGCCATGGACGGGTTCTCCGGGTTCAAGACCGCCGCCACCGAAGAACTGCCTGACGCGGCCACGGTGATGGACCCCTTCCACGTGGTCCGCCTGGCCGGCAACGCCCTCGACGAGTGCCGACGCCGCGTGCAGCTGGCCACCTGCGGGCACCGCGGCCGCAGCACCGACCCGCTCTACCGATCGCGACGCACCCTGCACACCGGGGCCGACCTGCTCACCGACCGCCAGAAAGCCCGACTGGCCGCACTGTTCGCCGCCAACGCGCACGCCGAGATCGAGGCCACCTGGGCGATGTATCAACGCACCGTGGCCGCCTACCGCGAACCAGACCGCACCAAGGGCCGCACCATGATGGCTGCACTGATCACCACGCTGAGCACAGGCGTCCCCACGTCGCTGACCGAGCTGATCACCCTCGGGCGGACACTGAAGAAGCGTGCCGCCGACGTCCTGGCCTACTTCGACCGCCCCGGCACCTCCAACGGGCCGACCGAAGCGATCAACGGCCGCCTCGAACACCTGCGCGGATCCGCCCTGGGCTTCCGCAACCTCACCAACTACATCGCCCGGTCCCTGCTCGAGACCGGAGGCTTCCGAACCCAGCTCCGTCAACCTCGGCGGTGA	MAHEPFGWRPTALLVTIRRYRCAGCAHVWRQDASAAAEPRARLSRRALRWALEALVCQHLSVARVAEALAVSWNTANNAVLAEGQRVLIADPARFDGVAVIGVDEHVWRHTRRGDKYVTVIIDLTPVRDGTGPARLLDMVEGRSKKAFADWLAQRPQEWRDRVDVVAMDGFSGFKTAATEELPDAATVMDPFHVVRLAGNALDECRRRVQLATCGHRGRSTDPLYRSRRTLHTGADLLTDRQKARLAALFAANAHAEIEATWAMYQRTVAAYREPDRTKGRTMMAALITTLSTGVPTSLTELITLGRTLKKRAADVLAYFDRPGTSNGPTEAINGRLEHLRGSALGFRNLTNYIARSLLETGGFRTQLRQPRR	MKKITFLLLMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDKKLPLLSVFKFHLACAVLDMADKGKFSTDQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIITYTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTNATVSLLKKFYDGKLLTKKSTDFLMQIMLGTTTGTNKIVEQLPKSTPVAHKTGSSGKPDNILTVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK	127.74	gnl|BL_ORD_ID|2549|hsp_num:0	3570			27	168	
BGC0000365.1|Glycopeptidolipid_17 # 18738 # 19490 # -1 # ID=1_17;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.653	BGC0000365.1|Glycopeptidolipid_17 	18738	19490	-	Loose	1700	28.1054	AxyY	30.77	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGCTTGGGGTGTGCCGGAGAAGAAGCGGAAGAGCAAGAGGAAGAGCGGAGTGTCCGGGGGCAGTGTGGACCTGGCGTTGCTGCAGAAGCTAATGGCCGACGCTGGTCGGAACGTGTTCGCGGGAATGTTCGATGAGCCGACGCCCGAGGTGCGGGCGGTGCCGGATCGTGCGCGGGGCTTCCGGGTGCGCGTCGACCTGATGTACGCCAAGCCGCCGATCTGGCGTCGGCTGGACCTGCCGGGCGACCTCATGCTCGATGAGCTCCATGTTGTGCTGCAGGTCGTTATGGGCTGGCAGGACAGTCATCTGCATAAGTTCGGTGTCGGGGCGGACCGGCGGACCCGTGCCTACTTCGTCACCGGGTTTGATCTCAGCGAAGGCGACGACGGTGTCGTCGAGGACAGCGTGCGCCTCGATCAGGTGGTGTCCGATAAGGGCGAGCGGTTGTTCTACGATTACGACTTCGGCGACGGATGGGACCACGTGCTCGTGGTCGAAGACGTTTTCGATGATCCGCCCCCGGCTGCGGTGTGTCTGACGGGAAAGATGGCCTGTCCGCCGGAGGACTGTGGTGGCCTGGGCGGCTATGAGGAGTTGGCTGCGTGGGTTCGCGGCGGGTACGACCCGCGGGAAACGCCGATGGGACTCGGTGCGCAGGAGATGAGGGACTGGCTGCCCCGGGGCTGGCACCCCGACCGTTTCTCGGTGGCCGAGACCAATGACGCTCTGGCCGCGTTGAACACGCGTTGA	MAWGVPEKKRKSKRKSGVSGGSVDLALLQKLMADAGRNVFAGMFDEPTPEVRAVPDRARGFRVRVDLMYAKPPIWRRLDLPGDLMLDELHVVLQVVMGWQDSHLHKFGVGADRRTRAYFVTGFDLSEGDDGVVEDSVRLDQVVSDKGERLFYDYDFGDGWDHVLVVEDVFDDPPPAAVCLTGKMACPPEDCGGLGGYEELAAWVRGGYDPRETPMGLGAQEMRDWLPRGWHPDRFSVAETNDALAALNTR	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	23.92	gnl|BL_ORD_ID|2411|hsp_num:0	2799			2082	2277	erythromycin; cefepime
BGC0000365.1|Glycopeptidolipid_18 # 20001 # 30296 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0000365.1|Glycopeptidolipid_18 	20001	30296	+	Loose	1000	165.622	almE	27.99	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGAACCTGTCGACGGGGCTCTACCGCTGTCGCGCGGGCAGCTGGACATCTGGCTCTCGCACGAGAGCGGATTGGCCGGCGCCGAGTGGCAACTCGGCCTCCTGGGCAAGATCGACGGTGTCGTCGATCATGGACTCCTGCAACAGGCCATCCGGCAAGCCCTGCAGGAGGCCGAGCCGGCGCGTGCCACCTTCTTCGAAGCCGACGGCCAGGTCTTCCAGAAGCCGCTCGACTACTCGGAACTGGAAGTACCGCTGTACGACGTCCGGGACGCCGACGATCCTGAGGCGAAGGCCCGGGAGATGGCCGCGGAGATCCAGCACACGCCGCTGCCGCTCACCGGTCGGCTGGTGAAGTTCGCGTTGTTCCAGACACGCGACGAGCAGTTCTACCTGTTCGGCCTGGGCCATCACATATCTGTCGATGGGCTCGGCATGGCTCTGGTGAGCCGTCGCATCTCCACCATCTATACGTCGCTGGTTACCGGTAAACCGGTGCCGGAGGCATATTTTGGGTCTCTCCGGGACCTCGTCGAATGCGAAATGTCCTACGAGAGCTCGGCGGACTACCAGGACGACCTGGCGTACTGGAGCGAGAACCTGCCTCCGGACACAGGTCTTGACCAGGGTCTGGCCCCCACCCCGCACGGGAAGAACGCATATACGCCATCGGCATCGGTGCCGATGGATCCCGCCATCGTCGGCCGGATCAAGGAGCTTTCGAAGACCCTTCGTATCAGGCGTTATTCGGTCACCACCGCAGCGTGCGCGCTCCTGGCGCAGTCATGGTCGTCGACCGGTGATCAGGTGGCGCTCGACTTCCCGGTGAGCCGGCGTGTGAGCCCGGAATCAAAGACGCTGCCTGCCATGCTCGCCGGTGTCGCGCCTCTCGTGCTCGACGCTCCGCCGCAGTTGACGGTCGGTGAGTTCTGCAAGCACGTCGACATCCGGATCAGGGAGCTGTTGCAACATCAACGGTTTCCGGTGCACCGGCTCGGCGACGGAGGGGCGTTGCGTGGCCCGCGTCAGGCCTCCAACCGCCTCGCGGTCAACTTCATCCCGTCGCGTCTGACACTCGACTTCGCGGGGGCGGAAGCGACGGCGTCGTACACGAACCACGGCCCCATGGGGCACTTCGGGCTTTTCTTCATCGGTGCGGGCGAGGAACTCTTCCTCAGCACCGCTGGGGCCGGGCAGCCGTTCGCCAATTTCGAGGTCCCGGAGTTGGCCGAACGCCTGGGCGCCATCGTTGCGGCGATGGCAGCCGACCCGGCTATGCCGCTGGCGGCGGTGAGGCTGCTGGCAGAGTCCGAATCCGACCGGCTCGCAACCATCGGAAACCACTCTGCGTTGTCCGAGTCTGCTCCAGACGCGGTGTCGATACCGGAGCGGTTCGCCGCTCGTGTGGCGGAGGCGCCCGACGCTGCGGCGCTGACATTCGAAGGTCGCACTTTGACCTACCGGGAACTGGACGAAGCGGCCAACCGCTTCGCCCACGCCCTCCTGGCGCGGGGCATCGGTCCTGGATCGCGCGTGGCCTTGATGTCACCGCGTACCGACCGGTCCGTCATCGCGATCCTCGGCGCGTTCAAAGCCGGAGCGGCATACGTGCCTGTCGATCCGGCAGTACCGGCGGCGCGGGTGCGGTTCATCCTCGACGACGCTTCTCCTGTCGCCGTGGTCACCACGGCGGAACTCCGGTCGCGGTTCGACGGTCACGATCTTGCTGTCATAGACATCGACGACCCGGCCATCGCCTCGCTGCCGGCCACCGCCGTTTCAGATCCGCGCCCAGACGACATCGCGTACGTCATCTACACGTCGGGAACGACGGGAACGCCCAAGGGCGTCGCGGTCACCCACAAGAACCTCACCCACTTGATCGCCGTGTTGGAGGAGCGTCTGCCGAAGCCTGGCGTCTGGCCTCTGTGCCATTCGCTGGCGTTCGACGCGTCGGTGTGGGAGATCAGCAATGCACTGCTGCGCGGGGGGCGGCTCGTCGTCGTGCCCGAGGCCGTCGCCGGCTCTCCGGAGGACTTCCACGACCTGCTGGTCGCGGAGCAGGTCACGTTCCTCACCCAGACCCCTTCGGCCGTTGCGATGTTGTCGCCGGACGGCTTGGAGTCGATGACGTTGGCCGTGGTCGGCGAAGCCTGCCCACCTGCCCTGGTCGACCGTTGGGCCACCAACCGAACGATGATCAACGCCTACGGCCCGACCGAGACGACGATCTGCGTCACCTCCAGTTCGCCGCTGGAGCCGGGGTCGGTTGTGGTGCCGATCGGCTCGGCGTTGCCGCGAACGGCCCTGTTCGTACTCGACCCGTGGCTGCGGCCGGTTCCCACCGGTGTCGCCGGTGAACTGTATGTGGCCGGCGACGGTGTCACATGCGGCTACATCGGCCGTTCCGGTCTGACGGCCTCGCGCTTTGTGCCCTGTCCTTTCGGTGAGCCGGGTGCGCGGATGTACAGGACCGGGGACCTGGTCCGATGGGGACGCGACGGTCAGCTGGAATACCTGGGCCGTGCGGACGAGCAGGTGAAGATCCGCGGCTACCGCATCGAACTCGGCGAAGTGCAGTCCGCTCTGGCGGCATTGGACGGCGTCGAAAGCGCAGCTGCGATCATGCGCGAAGATCGTCCAGGGGACAGGCGGCTGGTGGGTTACATCACCGGAACCGCCGATCCGGTCGACATCCGCGCCGAACTGGCGGACCGATTGCCGCCCTACATGGTGCCCACCGCCATCGTGGTGCTGCCGGCGCTCCCTCTGACATCGAGCAACAAACTCGACACACGTGCCCTGCCGGCCCCCGAATACGCGAACGCCGAGAAGAACTACCGGGCGCCGTCGAACCCGGTCGAGGAGGTCCTCGCCGACATCTACGCGCAGGTGCTGGGTGTGGAGCGGATCGGCGTGGACGATTCGTTCTTCGATCTCGGCGGCGACAGCATCCTGTCGATGCAGGTCGTGGCACGGGCACGTGCCGCGGGCATCCAGTGCCGCCCTCGTGACGTCTTCGTCGAACAGACCGTCGCCCGACTCGCCTCCGTGGCCACGGTTGCCACGGAGATCGGTGTCGTCGACGACGGAACCGGTTCCGCCGCGCCCACCCCGATCATCCACTGGTTGCGTGAAGCCGGGGGTGCCACCGACGAGTTCAACCAGACCCTGGTCGTGCAGGCCCCGACCGGCGTCACCGAACCCGACGTGGTCGCGGTGCTGCAGGCCCTGCTCGATCGGCACGCGACGTTGCGGTTGCGAGTTCAGGACAGCGACGGCGAATGGTCGCTGCTGGTGCCCGATGCGGCAACGGTCGACGCGCGTGACTGCCTCAGTGTGGTCGACACGCTCAGCGACGACGTCGTGCTGGCCGCGCGAGCGAAATTGAACCCCGCCGCCGGGGCAATGGTCAGCGCGCTGTGGGTGCGGCAGACCAGCCAGCTGGTGCTCATCATCCACCACCTCGCGGTCGACGGCGTGTCGTGGCGAATCCTGCTGGAAGACCTCAACATCGCCTGGGCGCAACACCACAGCGGCCAGCAGGTCCAGCTCCCGGCAGGCGGAACGTCGTTCCTCCGTTGGTCCAAGCGGCTGGCCGACCACGCGCACACCGCCGAGGTGACCGCACAGGCCGACGCCTGGCGAGAGATCCTGGCGAAACCCGCTGCCCTGCCGGCGGTCCAGCCGGACACCGACACCCACGCGAGCGCGGGGCGCTTCTCGGCGACGCTGGATCCCGAGACCACGCGTCAACTGCTCGGTGAAGTACCCGCGGCGTTCCACGCCGGTGTCCAGGACATCCTGCTGGTCGCCTTCGGTTTGGCATGGGCGGAGTTCCTGAATCGCTCGGGCACCCCGATCACGGTGGACGTCGAGGGCCACGGGCGTCACGAGGAACTCGCGTCCGACATCGACCTGTCGCGGACCGTCGGTTGGTTCACCACCAAGTACCCGGTCGCGCTGACCGTGGCTGACGTGCCGTGGGCGCAGGTCGTCGCCGGCGAAGCCACGCTGGGCGCTGTGGTCAAAGACGTCAAGGAACAGCTTCGCGCGGTGCCGGATGGTTTGACCTACGGTCTGTTGCGGTACCTGAATTCCGAAGTGGAGCTTGGTGGTACGGAGCCGACGATCGGTTTCAACTATCTGGGACGGCTGGGCGCCGGCGCCGGCGAACTGTCCGAGGAACTGTGGCGGATCGAGCAGGGCAGCCTGGCGCTGACCGACGTGGTGTCGGCCGTGCCGATGCCACTGGCGCACACCGTCGAGCTCAACGCGGGCACCATGGACACCGACAAAGGGCCGAGCCTGCAGGCCAGTTGGACGTGGGCCCCTTCGGTATTCGACGAAGACAAGGCGGCCCGCCTGAGCCAATTGTGGTTCGAGGCGCTGGCCGGGATCTGCGCACATGTCCAGGCAGGCGGTGGTGGCCTCACCCCGTCGGATATCGCGCCCGCACGTCTGACGCAGCGCGAGATCGACCAGCTGACAACGCAGTTCGAGGTCGCCGACGTACTTCCCCTCACCCCGCTGCAACAGGGCCTGCTGTTCCAGGCCGGGTTCGCCGAGGCCGCGGGCGCCGAGGCCGCGGGTGTGCCGAGCGACGATGTCTATGCCGTCCAACTGGGCATCACGCTCAGCGGCAGCCTCGATCCGCAGCAGTTGCGTGACGCCGTGCAGGCCGTGATCCGCCGTCACCCGAACCTCGCCGCACGGTTCGTCGAACAGTTCGGCGAGCCCGTGCAGGTCCTGTCCGTCGATCCAGAGATCGGCTGGCAATTCGTCGAATTCGACTCCGGCGACACCGGGGTGGACGAGCGCGTCGAACGACTCTGCGCAGCAGAGCGTTCAGCGGTGTGCAAGCTCGGCGAGCAGCCGGTGTTCCGTGCCGCGCTGATCCGCACCGCCGACAACCTCCATCGCTTCGTCCTGACGATCCACCACATCGTCATCGACGGGTGGTCGCTGCCGGTACTCCTGCAGGAGATCTTCGCCGCCTACTTCGACCAGTCGCTGCCGTCGGCAGCGCCGTACCGCAACTTCGTCACGTGGCTGGGCGCGCAGGACCGCGACGCCGCACAGGCGGCGTGGGGATCGGTGCTCGAAGGCTTCGAGACACCCACCCTCGTCGCGCCGCCCGCGCAGGCAGGCCCGCGTGGCGTCGAGTCCTTCCGGCTGTCCGAGGCCACCACCCGCACCCTCGGTGAGCTCGCCCGCTCGCAGCACACCACCGTCAACACCGTGCTGCAGGCCGCCTGGGCGCAGCTGCTGATGTGGATGACCGGCCAGCGCGACGTCGTGTTCGGCACCGCGGTCTCGGGCCGGCCCGTGGATCTGGCCGGCGCCGATTCGATGGTCGGTCTGTTGATCAACACCGTGCCGGTGCGCGCGACGAGCGGCGTGGCCACGACAGTTACCGATCTCCTCGGCCAGCTGCAGCGCGACCACAACGACACGGTGGACCACGAGCACATGGCGCTCAACGAGATTCACCGTCTCACCGGGCACGACCGGCTGTTCGACACGTTGTTCGTCTACGAGAACTACCCGATCGACGCCAACGCGCTGCTGAGCGTGCAGGATCTCGCGGTCACCGATTTCGCGAGCCGCGAGTACAACCACTATCCGCTGTCGATGGTCGCGACCCCGGGCCACGAGGTCGTGCTCCGCGTCGAATTCGACACCGAGATCTTCGACGCGGCGAGCATCGAGGCGCTGGTCGACCGGCTGCGGCGCGTCCTCGACGCGATGGCCACCGATCCCGGACGGCGGTTGTCGACGATCGATCTGCTCGACCCGCAGGAACACGATCGGCTCGACGAGTGGGGTAACCGGGCCGTGCTGACGCGTCCCGCACCCGCGCTCGAATCGATCCCGGCATCCTTCGCGGAAAGTGTCCGGCGCGTGCCCGATGCCGTGGCGCTCAGCTGCGGCGACCGGTCCTGGACGTACCGCGAACTCGACGAGGCCTCCAACCGGATGGCGCATCTGCTGGCCGGACGTGGCGCGAAACCCGGTGAGCGCGTGGCGATGTTACTGCCGCGCACCGGGGAAGCCGTCGTGACCATCCTCGCGATCCTCAAGACCGGGGCGGCCTACCTGCCGATCGACCCCGCGCATCCGGACGCCCGTATCGAGTTCGTGCTCAAGGACGCGGCGCCGGTCGCGGCCGTCTCGTCGGCCGACCTGTGCACCAGGCTCATCGCGTCCGGGGTACCGGTGATCGAGGTCGATGATCCGGCCATCGGGGCCGAGGCGAGCACGTCGCTGCCGGTCCCGGCGGTCGACGACATCGCCTACATCATCTACACCTCGGGTACCACCGGCACGCCGAAAGGCGTTGCCGTCACGCACCGTAACGTCGCGCAGCTGCTCGACACCCTCGGCGCCCAGCTGGAGCTGGGGCAGACGTGGACGCAGTGCCACTCGCTGGCCTTCGACTATTCGGTGTGGGAGATCTGGGGTCCCCTGCTCAACGGCGGGCGCCTGCTGATGGTCCCTGACGCGGTCGTCCGTTCGCCGGAGGACCTGCACGCGATGCTCGTCGCCGAGCAGGTGAGCATGCTCAGCCAGACCCCGTCGGCGTTCTACGCGCTGCAGACCGCCGACGCGCTGTATCCCGAACGCGGCGAGCAACTCAAGCTGCAGACCGTGGTGTTCGGCGGCGAAGCGCTTGAGCCGCACCGGCTGTCGGGCTGGATGCACGCCCACCCGGGCATGCCGCGCATGATCAACATGTACGGCATCACCGAGACCACGGTGCACGCGTCCTTCCGCGAGATCGGCGAGGCCGATCTCGCGAACAGCACCAGCCCCATCGGTGTGCCACTCGAGCACTTGTCGTTCTTCGTGCTGGACGGCTGGCTGCGTCAGGTGCCGGTCGGCGTGGTCGGCGAATTGTACGTGGCCGGAGAAGGTTTGGCGTGCGGGTACATCAGCCGTTCCGACCTCACGTCGACGCGGTTCGTCGCCTGCCCGTTCGGAGCGCCGGGAGCGCGGATGTACCGCACCGGCGACCTGGTGCGGTGGGGTGCCGACGGCCAGTTGCAGTACGTCGGACGCGCCGACGAACAGGTCAAGATCCGCGGCTACCGCATCGAACTCGGTGAGGTGCACGCGGCACTCGTCGGGCTCGACGGGGTCGAGCAGGCCGCGGTGATCGCACGCGAGGACAGGCCCGGCGACAAGCGGCTGGTCGGTTATGTCACCGGCGCGGTCGACCCGGTCAAGGCCCGGGCCGCGCTCGCCGAGCGGATCCCCGCGTACATGGTGCCCGCGGCGATCGTGGTGATGGAGTCGCTGCCGCTGACGGTCAACGGCAAGCTCAACACGCGCGCCCTGCCTGCCCCCGAGTACCAGGACGCCGACCAGTACCGCGCCCCCGCAAACGCCGTGGAGGAACTGCTCACCGGCATCTACGCACAGGTTCTCGGTGTGGAGCGGGTCGGTGTCGACGACTCGTTCTTCGATCTCGGTGGCGACAGCATCTCCTCGATGCAGGTGGTGGCGCGGGCACGCGCCGCAGGCCTGGTGTGCCGCCCGCGAGACATCTTCGTGGAACAGACCGTTTCCCGGCTGGCGCAGGTTGTCACCCTCGCCGACGGCGAGTCCGGCGTGGCCGACACCGGTGTCGGACCTGTCGTGGCCACCCCGATCATGCGCTGGCTGTACAGCCTTGACGGCCCGATCGATGAGTTCAACCAGACCGTGGTGCTGCAGGTCCCGGCCGAGGTGACCGAGGCGGACGTCATCGCGGTGCTCCAGGCGGTGCTGGATCACCACGCGATGCTGCGTCTACGGGTCGCGGATGCCGAGAACGGTGATCTGACGGTGCCGGAACCCGGCTCGGTCGATGCGTGTGATTGCCTGTGCACAGTCGGCGAATTGACCGCCGACACCCTCGCCGCGGTTCGCGCACAGCTCAACCCGGCGACCGGGTCGATGCTCACCGCGGCCTGGGTACCCGAGACACGGCAACTCGCGCTGATGATCCACCACCTCGCGGTCGATGCCGTGTCGTGGCGAATCCTGTTGGAGGACCTCAACATCGCATGGGCGCAGCATCGCAGCGGACAACCCGTGGTGCTGCCGACGCCGGGAACGTCGTTCGGCAGGTGGTCCAGGTTGCTGGATCAGCACGCACGTACGGCCGATGTGCTCGCCACCGCCGATGTGTGGCGCACGGTTGCCGCGGCGCCGGCCGCGCTGCCCGCGCCGCAACCGGACACCGACGTCTACGCGAATGCCGGTCAGCTGTCGGCCTCGCTCGACGTCGAGACCACGGGGCAGTTGCTGGGCGACGTGCCCGCGGCGTTCCACGCGGGGGTGCAGGACATTCTGCTGATCGCGTTCGGGCTGGCCTGGAGCGAGTACCTGGGCTCCGAGCAGGGATCCATCGGAATCGACGTCGAGGGCCACGGCCGAACCGAAGAACTGTTCGGTGATGCGGACCTGTCCCGCACCGTGGGTTGGTTCACCTCCAAGTACCCGGTGGCACTGGATTTCGATCGCAACACCGGCGGCATCTCCTGGGAGCAGGTCGTCAACGGCGACGCCGCGCTCGGCGCGGTGATCAAGAAGGCCAAGGAGCAGTTGCGCAGCGTTCCCGACGGCCTCACCTACGGACTGCTGCGGTACCTCAATCCCGATGTCGAACTGGACAATCCGGATCCCACGATCGGGTTCAACTACCTGGGCCGGCTCGGGGCGGGGGCCGCGGATCTGTCCGATGATCTGTGGCGGCTCGACCCGGACGCGGTGTCGCTGACCGCTGCGGGCGGGCGCGTGAACACCCCGCTGGGGCACACCGTCGAGCTCAACGCGGGCACGATGGACACCGAGGCCGGACCGCAACTGCAGGCCACCTGGACCTGGGCCCCGTCGGCACTCGACGAGGAACAGATCCAGAAGGTCAGCAAGCTGTGGTCGGATGCGCTGGCAGGGATCTGTGCCCACGTCCGCTCGGGTGGTGGCGGCTTGACGCCGTCCGATGTCGCACCTGCGCGGCTGAGTCAGCAGCAGATCGACGATCTCACAGCGCAATTCGACATGGTCGACGTGCTGCCGCTCACGCCGCTGCAGCACGGCCTGCTGTTCCACACCGGGCTGTCGCAGGACAGCGAGGACCTCTACGCGGTGCAGCTCGACATCTCGGTGTCGGGCCGGCTCGATGTGGAGCGCATGCGCGATGCGGTGCAGACGGTGATCACGCGAAGGCCCAACGTGGTCGCGCACTTCTACGAGGACTTCGGCGAACCGGTGCAGATCCTGCCCGCGAACCCCGAACTCGCGTGGCAATACGTCGACCTGAGCGGTCGGTCGGACATCGACGCGCAGATTGCGCAGATCTCGGCGGCCGAGCGGGCCGCGGTGTGCCGGCTCGGTGATCAGCCGCCGTTCCGCGCCGCGGTGCTGCGGACCGGCGAAGAGACCTACAGGTTTGTGCTGACCAACCACCACATCGTCCTGGACGGCTGGTCGAAACCGATTCTGCTGCAGGAGATCTTCGTCAGCTACTTCGGTCAGCGCCTGCCCGCGCCGGTACCGTACCGGCGATTCGTCTCGTGGCTGGCCGAGCAGGACAACGACGCGGCGCGCGCGGCGTGGCGTGGCGTGTTCAGCGGCTTCGAGACCCCGACACTGGTCGGCACGCCGGGATTGGCGCTCGGGCGCCGTGCCGTCGAGTCGTTCCAGGTGTCAGCGGAGACCACTCAGGCGCTCGGTGAACTGGCGCGCTCCTGCCACACGACCGTGAGCACCGTGCTGCAGGGGGCATGGGCGCAGGTGCTCATGTGGCTGACCGGGCAACCCGATGTGGCGTTCGGTACCGCGGTCTCGGGCCGCCCGACCGATGTGCCCGGTGCGGATTCGATGGTGGGTCTGTTGATCAACACCGTCCCGGTGCGTGCCACGATCACGCCGGAAACGACCGTCGCGAGCCTGATGAATCAACTGCAGGGCGCCTATACCGATACGCTGGATCACCAGCACCTGGCGCTCAACGAGATTCACCGGGCCACGGGGCATGATCAACTGTTCGACACAGTATTTGTCTACGAAAATTATCCGATCGACACAGCAGCGTTGCTGGGCGTTCAAGAGTTGTCCATCACGGATTTCACCAACCGCGAGTACAACCACTACCCACTTTCTGTGCAAGCCGTGCCCGGCCATGAGCTGGGGTTACGCGTCGAATACGACACGAACGTCTTCGATCGGCAACGCATCAAGAGGTTGGTGAACCGGTTGCAGCGGGTATTGGTGGCCATGACCGCGGATATGAGGGAGAAGTCATGA	MEPVDGALPLSRGQLDIWLSHESGLAGAEWQLGLLGKIDGVVDHGLLQQAIRQALQEAEPARATFFEADGQVFQKPLDYSELEVPLYDVRDADDPEAKAREMAAEIQHTPLPLTGRLVKFALFQTRDEQFYLFGLGHHISVDGLGMALVSRRISTIYTSLVTGKPVPEAYFGSLRDLVECEMSYESSADYQDDLAYWSENLPPDTGLDQGLAPTPHGKNAYTPSASVPMDPAIVGRIKELSKTLRIRRYSVTTAACALLAQSWSSTGDQVALDFPVSRRVSPESKTLPAMLAGVAPLVLDAPPQLTVGEFCKHVDIRIRELLQHQRFPVHRLGDGGALRGPRQASNRLAVNFIPSRLTLDFAGAEATASYTNHGPMGHFGLFFIGAGEELFLSTAGAGQPFANFEVPELAERLGAIVAAMAADPAMPLAAVRLLAESESDRLATIGNHSALSESAPDAVSIPERFAARVAEAPDAAALTFEGRTLTYRELDEAANRFAHALLARGIGPGSRVALMSPRTDRSVIAILGAFKAGAAYVPVDPAVPAARVRFILDDASPVAVVTTAELRSRFDGHDLAVIDIDDPAIASLPATAVSDPRPDDIAYVIYTSGTTGTPKGVAVTHKNLTHLIAVLEERLPKPGVWPLCHSLAFDASVWEISNALLRGGRLVVVPEAVAGSPEDFHDLLVAEQVTFLTQTPSAVAMLSPDGLESMTLAVVGEACPPALVDRWATNRTMINAYGPTETTICVTSSSPLEPGSVVVPIGSALPRTALFVLDPWLRPVPTGVAGELYVAGDGVTCGYIGRSGLTASRFVPCPFGEPGARMYRTGDLVRWGRDGQLEYLGRADEQVKIRGYRIELGEVQSALAALDGVESAAAIMREDRPGDRRLVGYITGTADPVDIRAELADRLPPYMVPTAIVVLPALPLTSSNKLDTRALPAPEYANAEKNYRAPSNPVEEVLADIYAQVLGVERIGVDDSFFDLGGDSILSMQVVARARAAGIQCRPRDVFVEQTVARLASVATVATEIGVVDDGTGSAAPTPIIHWLREAGGATDEFNQTLVVQAPTGVTEPDVVAVLQALLDRHATLRLRVQDSDGEWSLLVPDAATVDARDCLSVVDTLSDDVVLAARAKLNPAAGAMVSALWVRQTSQLVLIIHHLAVDGVSWRILLEDLNIAWAQHHSGQQVQLPAGGTSFLRWSKRLADHAHTAEVTAQADAWREILAKPAALPAVQPDTDTHASAGRFSATLDPETTRQLLGEVPAAFHAGVQDILLVAFGLAWAEFLNRSGTPITVDVEGHGRHEELASDIDLSRTVGWFTTKYPVALTVADVPWAQVVAGEATLGAVVKDVKEQLRAVPDGLTYGLLRYLNSEVELGGTEPTIGFNYLGRLGAGAGELSEELWRIEQGSLALTDVVSAVPMPLAHTVELNAGTMDTDKGPSLQASWTWAPSVFDEDKAARLSQLWFEALAGICAHVQAGGGGLTPSDIAPARLTQREIDQLTTQFEVADVLPLTPLQQGLLFQAGFAEAAGAEAAGVPSDDVYAVQLGITLSGSLDPQQLRDAVQAVIRRHPNLAARFVEQFGEPVQVLSVDPEIGWQFVEFDSGDTGVDERVERLCAAERSAVCKLGEQPVFRAALIRTADNLHRFVLTIHHIVIDGWSLPVLLQEIFAAYFDQSLPSAAPYRNFVTWLGAQDRDAAQAAWGSVLEGFETPTLVAPPAQAGPRGVESFRLSEATTRTLGELARSQHTTVNTVLQAAWAQLLMWMTGQRDVVFGTAVSGRPVDLAGADSMVGLLINTVPVRATSGVATTVTDLLGQLQRDHNDTVDHEHMALNEIHRLTGHDRLFDTLFVYENYPIDANALLSVQDLAVTDFASREYNHYPLSMVATPGHEVVLRVEFDTEIFDAASIEALVDRLRRVLDAMATDPGRRLSTIDLLDPQEHDRLDEWGNRAVLTRPAPALESIPASFAESVRRVPDAVALSCGDRSWTYRELDEASNRMAHLLAGRGAKPGERVAMLLPRTGEAVVTILAILKTGAAYLPIDPAHPDARIEFVLKDAAPVAAVSSADLCTRLIASGVPVIEVDDPAIGAEASTSLPVPAVDDIAYIIYTSGTTGTPKGVAVTHRNVAQLLDTLGAQLELGQTWTQCHSLAFDYSVWEIWGPLLNGGRLLMVPDAVVRSPEDLHAMLVAEQVSMLSQTPSAFYALQTADALYPERGEQLKLQTVVFGGEALEPHRLSGWMHAHPGMPRMINMYGITETTVHASFREIGEADLANSTSPIGVPLEHLSFFVLDGWLRQVPVGVVGELYVAGEGLACGYISRSDLTSTRFVACPFGAPGARMYRTGDLVRWGADGQLQYVGRADEQVKIRGYRIELGEVHAALVGLDGVEQAAVIAREDRPGDKRLVGYVTGAVDPVKARAALAERIPAYMVPAAIVVMESLPLTVNGKLNTRALPAPEYQDADQYRAPANAVEELLTGIYAQVLGVERVGVDDSFFDLGGDSISSMQVVARARAAGLVCRPRDIFVEQTVSRLAQVVTLADGESGVADTGVGPVVATPIMRWLYSLDGPIDEFNQTVVLQVPAEVTEADVIAVLQAVLDHHAMLRLRVADAENGDLTVPEPGSVDACDCLCTVGELTADTLAAVRAQLNPATGSMLTAAWVPETRQLALMIHHLAVDAVSWRILLEDLNIAWAQHRSGQPVVLPTPGTSFGRWSRLLDQHARTADVLATADVWRTVAAAPAALPAPQPDTDVYANAGQLSASLDVETTGQLLGDVPAAFHAGVQDILLIAFGLAWSEYLGSEQGSIGIDVEGHGRTEELFGDADLSRTVGWFTSKYPVALDFDRNTGGISWEQVVNGDAALGAVIKKAKEQLRSVPDGLTYGLLRYLNPDVELDNPDPTIGFNYLGRLGAGAADLSDDLWRLDPDAVSLTAAGGRVNTPLGHTVELNAGTMDTEAGPQLQATWTWAPSALDEEQIQKVSKLWSDALAGICAHVRSGGGGLTPSDVAPARLSQQQIDDLTAQFDMVDVLPLTPLQHGLLFHTGLSQDSEDLYAVQLDISVSGRLDVERMRDAVQTVITRRPNVVAHFYEDFGEPVQILPANPELAWQYVDLSGRSDIDAQIAQISAAERAAVCRLGDQPPFRAAVLRTGEETYRFVLTNHHIVLDGWSKPILLQEIFVSYFGQRLPAPVPYRRFVSWLAEQDNDAARAAWRGVFSGFETPTLVGTPGLALGRRAVESFQVSAETTQALGELARSCHTTVSTVLQGAWAQVLMWLTGQPDVAFGTAVSGRPTDVPGADSMVGLLINTVPVRATITPETTVASLMNQLQGAYTDTLDHQHLALNEIHRATGHDQLFDTVFVYENYPIDTAALLGVQELSITDFTNREYNHYPLSVQAVPGHELGLRVEYDTNVFDRQRIKRLVNRLQRVLVAMTADMREKS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	617.09	gnl|BL_ORD_ID|4935|hsp_num:0	5928			135	1629	colistin A; colistin B
BGC0000365.1|Glycopeptidolipid_19 # 30293 # 37972 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.677	BGC0000365.1|Glycopeptidolipid_19 	30293	37972	+	Loose	1000	152.525	almE	28.07	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACTGCCGAACCGTCCACGCGGACTCTGCTGTCGTTCGACCTCCTCGACGAGGACGAGCACGACCAGATCGAGGTATGGGGTAACCGCGCGGTCCTGACCGACCCGGGCCCGACGCCGGTCACCATTCCCGCGCTGTTCGCCGAACAGGTGGTCCGCGCCCCGGACGCGGTCGCGCTCGTGTCCGGCGACCGCTCGTGGACCTACCGCGAACTGGACGAGGCCTCCAACCGGCTGGCACATGTGTTGGCCGAACACGGTGCGAAACCCGGTGCGACAGTGGCGTTCTTGATCCCGCGGTCCGGCGAGGCGATTCTGTCGATCCTCTCGGTGCTCAAGACAGGTGCCGCATATCTGCCCGTCGACCCGGCACACCCCGACGCGCGCATCGGGTTCATGATGTCCGATGCGAAGCCCGTAGCGGCGCTGACCACCGCTGACCTGCGGTCACGTCTCGACCAGTACGACCTTGCCGTCATCGACATGGCAGATCCGGCGATCGACCGGCGTCCCAGCGACGCGCTGTCCGGGCCCAGGCCCGACGACCTCGCCTACATGACCTACACGTCCGGCACCACCGGCGTGCCCAAGGCCGTCGCCGTCACCCACCACAACGTCACCCAATTGGTGAGCGCACTGCACGCCGACCTCCCTTCCGGGCCCGGCCAGGTGTGGTCGCAGTGGCATTCGCTGGTGTTTGACGTCTCGGTGTGGGAGATCTGGGGTGCCCTGCTGCACGGCGGCCGGCTGGTCGTCGTCCCCGAGTCCGTCGGCAGCTCGCCCGACGACCTGCACAACCTGCTGATCACCGAGAAGGTCAGTGTGCTGTGCCAGACGCCGTCCGCGGCAGGCATGTTGTCTCCGGAAGGGCTCGAGTCGACGACGCTGATCGTCGCAGGCGAGGCCTGCCCGACCGAGCTGGTCGATCGATGGGCCCCGGGCCGCGTCATGATCAACGCGTACGGCCCGACCGAGGCCACCATCTACGCGGCGATGAGCGAGCCCCTGACGGCGGGCACGGGCGTCGCTCCGATCGGTGCTCCCGTCCCCGGCGCGGCCCTGTTCGTGCTGGACAAGTGGCTGCGCCCCGCTCCCGAAGGCGTGGTCGGTGAGCTGTACGTGGCCGGACACGGCGTCGCGACTGGCTACATCGGGCGTCCGGATCTGACCGCGTCGCGGTTCGTGGCGTGCCCGTTCGGCGAAACCGGCGAGCGGATGTACCGCACGGGAGATCTGGTTCGTTGGGGTTCGGACGGTCAGCTGGAGTACCTCGGCCGTGCCGACGAGCAGGTCAAGATCCGTGGTTACCGCATCGAACTCGGCGAGATCCAGGCCGCGCTGGCCAAGCTGGACGGCGTCGACCAGGCCGTCGTGATCGCCCGTGAGGACCGCCCCGGCGACAAGCGCCTGGTGGGTTACATCACCGGGACCGCCGATCCGGCACAGCTGCGTACGGCCCTGGCCGAGAGCCTGCCCGCCTACATGGTCCCCACCGCGGTGGTGGTGCTGGATACCATCCCCTTGACGGTCAACGGGAAACTCGACCGCCGGGCCCTGCCCGCACCTGAATATCGCAGTGCGGCAAACGATTACCGTGCACCGTCGACACCGGCCGAGCAGATCCTCGCCGACGTCTACGCGCAGGTGCTAGGTGTCGAGCGGGTGGGTGTCGACGATTCGTTCTTCGACCTCGGCGGCGACAGCATCCTGTCGATGCAGGTGGTCGCCCGGGCGCGGGCCGCTGGGATCCAGTGCCGCCCGCGCGACATCTTCGTCGAGCAGACCGTCGCCGGTGTGGCCCGCGTGGCCGTCGCGGCCGGTGAATCCCACGTCGTCGACGAGGGTGTCGGCCCGGTGGTCGCCACCCCGATCATGCGTTGGCTGCGCGAAGTCGACGGACCCACCGGTCAGTTCAACCAGACGGTGATCACCCAGGCTCCGGCCGGTGTCACCGAGGACGACGTGGTGGTGATCCTGCAGGCGCTGCTGGATCGGCACGCGACGCTGCGACTGCGGGTCGAGGACACGCAAGAAGACACCGACGAGTGGTCGCTGCTGGTGCCGGAGGCCGGCGCCGTCGGGGCCCGCGAGTGCCTTCGCACCGTCGACGCACTGACCGACGACGTACTGGTCGAGGCGCGCAACCGCCTCGATCCCGCCGCCGGTGCCATGGTCAGCGCGGTCTGGGTGCGCGAGACGAGCCAACTGGTGCTGATGATCCACCACCTCGCGGTCGACGGGGTGTCGTGGCGAATCCTTTTGGAAGACCTCAACATCGCCTGGGCCCAGCACTGCACCGGGCAGTCCATTGAGCTGCCTGCAGGCGGCACGTCGTTCGCGCGCTGGAGCGCTCTGCTGGCCGAACACGCGAAGACCGATACGGTGCGCGACCTCGCCGACGCATGGCGCGCGGTCACCTCCGTCCCACAGGCACTGCCGCCGGTGCAGCCCGACACCGACACCTACGTCACAGCCGGGCAGCTCTCGGCCTCGCTGGACGTGGAAACCACACGTCAGCTGCTGGGTGAGGTGCCCGCGGCGTTCCGCGCCGGTGTCCAGGACATCCTCCTGGTCGCCTTCGGGCTGGCATGGACCGAGTTCCTGAACCGCTCGGACACCCCGATCGGCGTCGACGTCGAGGGCCACGGCCGCTACGACGAACTGGCATCCGACGTCGACCTGTCACGCACGGTCGGCTGGTTCACCACCAAGTACCCGGTCGCGCTGACCGTGGAAAATTTGCCGTGGGAGCAGGTCGTCGCCGGTGACGCCGCGCTCGGTGGGATCGTCAAGGCCGTCAAGGAGCAGTTGCGGTCGCTGCCCGAGGGTCTGACCTACGGTTTGTTGCGGTACCTGAATCCCGAAGTGGACCTGGGTGGTTCGGATCCGACGATCGGTTTCAACTACCTGGGACGGCTGGGCGCCGGCGCCGGCGAACTGTCCGAGGAACTGTGGCGCATCGACCAGGACAGCCTCGCGCTGAGCGACGCGGCGTCCGCGGTGCCCATGCCACTGATGCACACCGTCGAGCTCAACGCGGGCACCATCGACACCGACAACGGACCGAGCCTGCGTGCCAGCTGGACGTGGGCCCCTTCGGCGTTCGACGAGGAGCAGGCCACGCGGTTGAGTCGGCTCTGGTTCGAGGCGCTGGCGGGGATATGCGCGCACGTCCGAGGCGGCGGCGGTGGCCTCACCCCGTCCGATGTCGCACCTGCGCGCCTGACCCAGCGTCAGATCGACGAACTGTCCCAGCGCTACGACGTCACCGACGTCCTGCCGCTCACGCCGGTCCAGCAGGGTCTGCTGTTCCACTCGACGTTCGCGCGCGGTATCGGTGACGACGTCTATGCGGTGCAACTCGACATCACCATCACCGGTGTTCTCGACCAGCACCGTCTCCGGGACGCTGTGCACACGGTCGTGGCGCGGCACCCCAACCTCGCGGCGCGGTTCGTCGAACAGTTCGGCGAACCGGTGCAGGTGCTCACGGCCGATCCGATGATCGCGTGGCGGTACCTGGATCTGCGCGGAGACGATCTCACGCCCGACCACGAGATCGAGCAGTTGTGCGCCGCCGAGCGCTCGGCCGTGTGCGATCTGCTCGAACGGCCGACGTTCCGCGCCGCGCTGATCCGTACCTCGGGTAATCAGCACAGGTTCGTACTGACGTTCCACCACATCGTCATCGACGGCTGGTCGTTGCCGATCTTGCTGCAGGAGATCTTCGCCGGGTACTTCGGGCATCGGCTGCCCGCCGCGGCGCCGTACCGCAATTTCGTCAATTGGCTTGCGACGCAGGACGCCACCGCCGCCAAAGCGGCATGGCGTGAGGTGCTCGACGGGTTCGAGACACCCACCCTGGTCGCACCGCCCGGCGTACCCGGGCCGCGGGGTATCGAGTCGTACCGCGTGTCCGCCGAAACCACGCGCGCCCTCGGTGAACTCGCGCGGTCACAGCACACCACCATCAACACCGTGCTGCAGGCTGCGTGGACCCAGCTGCTCATGCGGATGACCGGTCAGCGCGACGTCGCGTTCGGCACGGCGGTATCGGGGCGGCCTGCCGACCTGGCCGGCGCGGAGTCGATGGTGGGCCTGTTGATCAACACCGTGCCGATCCGGGCGAAGGTCTCGGCGGACACCACAGTGGGTGATCTGTTGCGTCAGCTGCAGAGCCATCACAACGACACACTCGAGCACGAGCACTTGGCACTCAACGACATCCACCACGTCTCGGGGCACGAGCAGCTGTTCGACACGTTGTTCCTGTACGAGAGCTACCCGATCGACACGAGCGCGTTCATGGGTGTGCAGGAGCTGGCGGTCACCGAGTTCAACAACCGCGAGTACAACCACTACCCGCTCTCGGTGATGGCGCTGCCCGGGCACGAACTGGGCCTACGCGTGGAGTACGACACCTCGGTGTTCGACGTCAGCGAGATCGAGACCTTGATCGACCGGTTCCAGCGGCTGCTGGAGGCCATGATCGACGACCCCGCTCGGCGCCTGTCGTCGATGGACGTCGTCGACGACGACGAGCGCACACAGCTCGACGAATGGGCCAACCGTGCGGTCCTCACGCAGCCGGTCGACTCTCCGCAGTCCATCCCGGAGGTGTTCGCCCGACAGGTGGAGCGCGATCCCGAGGCGCCGGCGGTCACCTTCGAGGGCGAGTCGCTCAACTACGGCGAACTCGACGAGGCCGCAAATCAGTTGGCGAACCTGCTGGCGGTTTACGGTGCCGCGCCGGGGAAGTCCGTGGCCCTCATGGTGCCCCGTTCGGCCGATGCCATCGTCGCGATCCTCGCGGTGCTCAAGACCGGGGCGGCGTACCTGCCGATCGACCCGTCGGTACCCGCCGCGCGGTTGGAGTTCATGCTCGGTGACGCCAAGCCCGTCGCCGCCGTCACCACCGGTGATCTGCGTTCCCGCTTCGACGGTTTCGATCTGCAGGTCGTCGAGGTCGACGATCCAGCGGTCGAGATCTACCCCAGCACAACGCTGCTCACGCCTTCGCCGGACGACATCGCGTACATGATCTACACGTCGGGAACCACCGGTGTGCCCAAGGGCGTGGCGATCACACACGGCAACGTGACACAGGTGCTCGACACGTTGCCTGCCGAGCTGCCCGCCGGACCTGGCGCGGTGTGGTCGCAATGGCATTCGCTGGTGTTCGACGTCTCGGTGTGGGAGATCTGGGGTGCGCTGCTGCACGGTGGCCGTCTGGTGATCGTGCCCGAGTCGATCGCCGGCTCGCCCGACGACCTGCACGCGCTGCTGGTCTCCGAAGGGGTCAACGTGCTCTACCAGACCCCCTCGGCGGTGCGGATGATGTCGCCGGAGGGATTGGAAGGCACCGCGCTGGTGGTGGCGGGCGAGGCCTGCCCCACCGAGGTCGTCGACCGCTGGGCCGTCGATCGCGTGATGATCAACGCCTACGGACCGACGGAATCCACGATCTACGCGGCCATCAGCGCGCCGCTCTCGCCGGGGTCCGATGTGGTCCCGATCGGCTCGCCGGTACCCAAGGGAGCGACCTTCGTCCTCGACGAGTGGCTGCGCCCCGTGCCGCCGGGGGTGGTCGGCGAGCTGTACCTGGCAGGTCGCGGTGTCGGCGTGGGCTATGTGGGCCGCAGCGGCCTGACCGGGACACGCTTCGTGGCGTGCCCGTTCGGCGAGCCGGGTGCGCGGATGTACCGCACCGGCGATCTCGTGCGATGGGGTGACGACGGGCAGCTGCAGTACCTGGGCCGTGCCGACGAGCAGGTCAAGATCCGCGGCTACCGCATCGAGCTCGGCGAGATCCAGGCAGCATTGTCCGACGTGGACGGCGTCGACCAGGCGGTCGTGATCGCCCGCGAGGACCGTCCCGGCGACAAGCGACTGGTGGGTTACATCACCGGTACCGCCGACCCGGCGGCCGCCCGCTCCGAACTCACCAACCGACTGCCCGCCTACATGGTCCCGGCTGCGGTGGTCACGCTGGAGACGCTGCCGTTGACCGTGAACGGCAAGCTCGACCGGCGCGCGCTGCCCGCGCCCGAATATCAGAGCGCCCAGCGCTACCGGGCACCGGAGACCGAGACCGAGAAGACCCTCGCCGGCATCTTCGCCCATGTGCTGGGCGTCGAACGGATCGGCCTCGACGACTCGTTCTTCGACCTCGGCGGGGACTCGATCTCGGCCATGCGTGTCACAGCCGCAGTCAACACGGCGCTCGACGCCGACCTGTCGGTGCGCACGCTGTTCGAGGCACCGACCGTGGCGAAGTTGAGCCTGCACGTCGAACACGACGCCGGTGAGCGGACCGACAGGGTCAGCTTCGCAGCGGTGCACGGCAGCGACGTCACCGAGGTGCATGCGCGCGATCTGACACTGGACAAGTTCATCGACGCTCCGACACTGCGGACCGCGACGACCCTGCCCCGACCCGACGGCGCCGTGCAGACGGTCCTCCTGACCGGGGCCACCGGATTCCTAGGGCGCTACCTGCTGCTGGAATGGCTGAGGCAGTTGCGGCGTGTCGACGACAAGGTGATCTGCCTGGTGCGCGGAAAGTCCGACGAGGACGCCCGCAGGCGCCTCGAGGCCACTTTCGACACAGATCCGTTGCTACGCAAGCATTTCAACGAACTGGCCACCGAGCGCCTGCAGGTCGTCGCGGGCGACAAGGGACAACCGAACCTCGGGCTCGACGAACAGACCTGGCAGCGGCTGGCCGAAAGTGTCGACCTGATCGTCGATTCGGCGGCATTCGTCAACAGTGTGCTGCCCTACAGCGAACTGTTCGGACCCAACGTGGTGGGCACGGCCGAGCTGATCCGGTTCGCGCTGACCTCGAAACTCAAGCCGTTCAACTTCGTGTCGACGTCGGACGTCGGCAGGCAGATCGAGCCGTCGCGGTTCACCGAGCAGGCCGACATCCGGTTGGTCAGCGCGACCCGCAAGATCGAGGTCGGGTATGCCAACGGCTACGGCAACAGCAAGTGGGCAGGCGAGGTGCTGCTGCGCGAGGCCCACGACCACTGCGGCCTGCCGGTGGCGGTGTTCCGGTCGGGCATGATCATGGTCGACCCGACCTACGCCGGGCAGCTGAACGTCACGGACACGGTGTCGCGCATGGTGCTCAGCATCGTGGCCACCGGTGTCGCACCCGGGTCGTTCTATCAGCGCGGTGACAACGGTGAGCGGCAGCGGGCACACTTCGACGGCTTGCCCGTCGACTTCGTCGCCCAGGCCATCACCAAGCTCGGCTGGCAGGTCGCGAGGTCGGTGACCGATTCCACCGCAAGCGGTTTCGAGACTTATCACGTGATGAACCCGCATGACGACGGCATCGGCATCGACACCTACATCGACTGGCTCATCGAGGCCGGATACCCGATCGAACGCATCGAGGACTTCGGAGAGTGGTTGCAGCGGTTCGAAGCGGCCCTGCAGGGGCTGTCGGACCAACAGCGGCAGAACTCCGTGCTGCAGATGCTGACGTTGCTCAAGCAGCAGGCGGGGGAGCTGCAGCCACCAGTGCCCACCCGGGGCTCGTTTGCGCCGGCAGACCGGTTCCAGGCCGCGGTCCGCGATGCGAACATCGGTGTGGAAGGCGAGATTCCGCATGTCACGCGGGAGGTCATCGTCAAGTACGTGACCGATCTGCAGCTGCTCGGGCTGCTGTAG	MTAEPSTRTLLSFDLLDEDEHDQIEVWGNRAVLTDPGPTPVTIPALFAEQVVRAPDAVALVSGDRSWTYRELDEASNRLAHVLAEHGAKPGATVAFLIPRSGEAILSILSVLKTGAAYLPVDPAHPDARIGFMMSDAKPVAALTTADLRSRLDQYDLAVIDMADPAIDRRPSDALSGPRPDDLAYMTYTSGTTGVPKAVAVTHHNVTQLVSALHADLPSGPGQVWSQWHSLVFDVSVWEIWGALLHGGRLVVVPESVGSSPDDLHNLLITEKVSVLCQTPSAAGMLSPEGLESTTLIVAGEACPTELVDRWAPGRVMINAYGPTEATIYAAMSEPLTAGTGVAPIGAPVPGAALFVLDKWLRPAPEGVVGELYVAGHGVATGYIGRPDLTASRFVACPFGETGERMYRTGDLVRWGSDGQLEYLGRADEQVKIRGYRIELGEIQAALAKLDGVDQAVVIAREDRPGDKRLVGYITGTADPAQLRTALAESLPAYMVPTAVVVLDTIPLTVNGKLDRRALPAPEYRSAANDYRAPSTPAEQILADVYAQVLGVERVGVDDSFFDLGGDSILSMQVVARARAAGIQCRPRDIFVEQTVAGVARVAVAAGESHVVDEGVGPVVATPIMRWLREVDGPTGQFNQTVITQAPAGVTEDDVVVILQALLDRHATLRLRVEDTQEDTDEWSLLVPEAGAVGARECLRTVDALTDDVLVEARNRLDPAAGAMVSAVWVRETSQLVLMIHHLAVDGVSWRILLEDLNIAWAQHCTGQSIELPAGGTSFARWSALLAEHAKTDTVRDLADAWRAVTSVPQALPPVQPDTDTYVTAGQLSASLDVETTRQLLGEVPAAFRAGVQDILLVAFGLAWTEFLNRSDTPIGVDVEGHGRYDELASDVDLSRTVGWFTTKYPVALTVENLPWEQVVAGDAALGGIVKAVKEQLRSLPEGLTYGLLRYLNPEVDLGGSDPTIGFNYLGRLGAGAGELSEELWRIDQDSLALSDAASAVPMPLMHTVELNAGTIDTDNGPSLRASWTWAPSAFDEEQATRLSRLWFEALAGICAHVRGGGGGLTPSDVAPARLTQRQIDELSQRYDVTDVLPLTPVQQGLLFHSTFARGIGDDVYAVQLDITITGVLDQHRLRDAVHTVVARHPNLAARFVEQFGEPVQVLTADPMIAWRYLDLRGDDLTPDHEIEQLCAAERSAVCDLLERPTFRAALIRTSGNQHRFVLTFHHIVIDGWSLPILLQEIFAGYFGHRLPAAAPYRNFVNWLATQDATAAKAAWREVLDGFETPTLVAPPGVPGPRGIESYRVSAETTRALGELARSQHTTINTVLQAAWTQLLMRMTGQRDVAFGTAVSGRPADLAGAESMVGLLINTVPIRAKVSADTTVGDLLRQLQSHHNDTLEHEHLALNDIHHVSGHEQLFDTLFLYESYPIDTSAFMGVQELAVTEFNNREYNHYPLSVMALPGHELGLRVEYDTSVFDVSEIETLIDRFQRLLEAMIDDPARRLSSMDVVDDDERTQLDEWANRAVLTQPVDSPQSIPEVFARQVERDPEAPAVTFEGESLNYGELDEAANQLANLLAVYGAAPGKSVALMVPRSADAIVAILAVLKTGAAYLPIDPSVPAARLEFMLGDAKPVAAVTTGDLRSRFDGFDLQVVEVDDPAVEIYPSTTLLTPSPDDIAYMIYTSGTTGVPKGVAITHGNVTQVLDTLPAELPAGPGAVWSQWHSLVFDVSVWEIWGALLHGGRLVIVPESIAGSPDDLHALLVSEGVNVLYQTPSAVRMMSPEGLEGTALVVAGEACPTEVVDRWAVDRVMINAYGPTESTIYAAISAPLSPGSDVVPIGSPVPKGATFVLDEWLRPVPPGVVGELYLAGRGVGVGYVGRSGLTGTRFVACPFGEPGARMYRTGDLVRWGDDGQLQYLGRADEQVKIRGYRIELGEIQAALSDVDGVDQAVVIAREDRPGDKRLVGYITGTADPAAARSELTNRLPAYMVPAAVVTLETLPLTVNGKLDRRALPAPEYQSAQRYRAPETETEKTLAGIFAHVLGVERIGLDDSFFDLGGDSISAMRVTAAVNTALDADLSVRTLFEAPTVAKLSLHVEHDAGERTDRVSFAAVHGSDVTEVHARDLTLDKFIDAPTLRTATTLPRPDGAVQTVLLTGATGFLGRYLLLEWLRQLRRVDDKVICLVRGKSDEDARRRLEATFDTDPLLRKHFNELATERLQVVAGDKGQPNLGLDEQTWQRLAESVDLIVDSAAFVNSVLPYSELFGPNVVGTAELIRFALTSKLKPFNFVSTSDVGRQIEPSRFTEQADIRLVSATRKIEVGYANGYGNSKWAGEVLLREAHDHCGLPVAVFRSGMIMVDPTYAGQLNVTDTVSRMVLSIVATGVAPGSFYQRGDNGERQRAHFDGLPVDFVAQAITKLGWQVARSVTDSTASGFETYHVMNPHDDGIGIDTYIDWLIEAGYPIERIEDFGEWLQRFEAALQGLSDQQRQNSVLQMLTLLKQQAGELQPPVPTRGSFAPADRFQAAVRDANIGVEGEIPHVTREVIVKYVTDLQLLGLL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	460.25	gnl|BL_ORD_ID|4935|hsp_num:0	5928			135	1629	colistin A; colistin B
BGC0000365.1|Glycopeptidolipid_20 # 37989 # 38807 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.619	BGC0000365.1|Glycopeptidolipid_20 	37989	38807	+	Loose	1300	29.261	mdtO	53.33	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTGGAGCGACATACTCGGGTTGGCACTGTTCGTGTCGCTGAACCCGTTGCTTCTCGGGTTCATCCTCTTGGTGCTATCCCGCCCCCGCCCGGTGCCCAACCTGGTTGTTTTCTGGGTTGGTTGCCTCATCGTGAATGTGCCGGGCTTCCTGATCCCGTTGTTCGTGCTGCGCGCAGTACCGTCGTTCGCGGAGTTCGCAGAAGACCTCACGACGGCGGATCCGTCCTCCGGCATCGAGCCGTTCCAGTTGGGCACCGGTATATTTGCCCTGGCTGTCAGCGCGGTGATCGCTCTTCGCATGTGGGTGAAAAGGCGAGCCAACCAGCCAGTGCTGGTCGGTTCAGGGGCCGGGGATCGGGGCCCCACGGATGACGCGTCGACTCTCGTGTTGGACTCGGGTGCGCGAGAGGCCCGTGAGCCGGGTGCCATAGCCAGGATGATCTTGCGAATGAGATCAGCGCTTCAGCGCCTCGTGAGCCGTCTCCACCAGGAGTGGGAGAACGGCGCACTATGGGTGGCGCTGGTTTTCGGTCTGGCGTACATACCGCCGCCACCACTGGTGTTGTTGGTCGACACGATCATCGGAGGATCTGGAGCTCCGATCGGCACCCAGATCATCGCTGTCTTCGTGTTCATCATGGCCATGCTCGCGGTTTTTGAGATCACGCTTCTCAGCTACGTCATCGCGCCGAGGCGGACCCAGGCGGTGTTGGAGCCGCTGCATGAGTGGTCGCACAGGCACCGCCAGATGATCCTGTTGGTCCTTTTCGGTGCGGTCGGGATCTGGGAGTTGATCGTGGGCCTCGGGGTCATCTGA	MWSDILGLALFVSLNPLLLGFILLVLSRPRPVPNLVVFWVGCLIVNVPGFLIPLFVLRAVPSFAEFAEDLTTADPSSGIEPFQLGTGIFALAVSAVIALRMWVKRRANQPVLVGSGAGDRGPTDDASTLVLDSGAREAREPGAIARMILRMRSALQRLVSRLHQEWENGALWVALVFGLAYIPPPPLVLLVDTIIGGSGAPIGTQIIAVFVFIMAMLAVFEITLLSYVIAPRRTQAVLEPLHEWSHRHRQMILLVLFGAVGIWELIVGLGVI	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	39.82	gnl|BL_ORD_ID|1893|hsp_num:0	2056			39	129	acriflavine; puromycin
BGC0000365.1|Glycopeptidolipid_21 # 38909 # 39319 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	BGC0000365.1|Glycopeptidolipid_21 	38909	39319	+	Loose	275	26.5646	AAC(6')-Iv	37.74	3002566	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGGCCAAGTACCTGCTTCTCAAGCACTACCGCGGCGCGCCGGCAGCGGTCAACGATGTGCCGATGGACCAGTGGGCACCGGACGAGATCGAGGCCCATCTCCAGTACATGAAGAGCCTCGCGACGCATCTGGAGAGCACCGGCGAGTTTGTCGACGCGCAGGCACTCGCCCCGACCGGGGCGTGGGTGCGCTACGACGGTGAGGGCAGACCGCCCGTCACCGACGGACCCTTCGCCGAGACCAAGGACCTCGTCGCCGGTTGGATGATCATCGACGTCGACTCGTACGAGCGGGCTGTCGAGGTGGCGGGGGAGTTGTCGGCCGCGCCGGGCGCCGGCGGAAAGCCGATCCACGAGTGGCTCGAGGTGCGGCCGTTCCTGGGTGATTCGGACGCCTGCCACGGGGAGTAG	MAKYLLLKHYRGAPAAVNDVPMDQWAPDEIEAHLQYMKSLATHLESTGEFVDAQALAPTGAWVRYDGEGRPPVTDGPFAETKDLVAGWMIIDVDSYERAVEVAGELSAAPGAGGKPIHEWLEVRPFLGDSDACHGE	MKIMPISESQLSDWLVLRCLLWPDHEEQHLQEMRQLITQAHCLQLLAYTDTQQAIAMLEASIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGIATGLVQHVEIWAKQFSCTEFASDAALDNQITHAMHQALGFQETERVVYFKKNIG	93.15	gnl|BL_ORD_ID|719|hsp_num:0	784			66	225	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000365.1|Glycopeptidolipid_22 # 39328 # 40503 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000365.1|Glycopeptidolipid_22 	39328	40503	+	Loose	540	28.8758	rmtE	30.0	3004678	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGGATCCGGCGGCCCTGCGGGACCTGATCCCCGGCGTCCTCGCGGCCCTCGTGCGCCGCGGCGTCGATTTCGCCACAGCCGAGGACGCGGTCCAGGAAGCCCTGATCAAGGCACTGGAAACATGGTCGACCGGCCGGGCGCCCGATGATCCGAAGGCCTGGCTGATCACGACCGCGTGGCGCCGGTTCATCGACGTCGCCCGCGCCGAGGCCGCGCGTCGTAGCCGCGAGCTACGGACCGCGGTCGAGGATCCGCAGGGTCCCACGGTTCCGGTGGACGACACGCTGCAGCTGTACTTCCTGTGTGCACACCCGAGTCTGAGCCCGGCGTCGGCCGTGGCGCTTACGCTGCGAGCGGTCGGCGGCCTCACCACCCGGCAGATAGCGAGGGCCTACCTGGTGCCCGAATCGACCATGGCCCAACGGATCAGCCGCGCCAAGCGCACGGTCAGCGAGGTCCGGCTGAACCGGCTGGGCAACCTCGGCACGGTGCTGAGGGTCCTGTACCTGGTGTTCAACGAGGGCTACACGGGCGACGTCGACCTTTCCGCCGAGGCGATCCGGCTGGCCCGCCAACTCGCGGCCGCCACCGACGCCCCGGAGGTCGCCGGATTGCTGGCACTGTTCCTGCTGCACGACGCCCGGCGACCGGCCCGCACGCGTGCCGACGGGACCCTGGTACCCCTCGCCGAGCAGGACCGCACGCTGTGGCGCCATGATCTGATCACCGAGGGTGTGGCCGTGCTGCAGGCCGCGCTGGCGGCCGACCGGCTCGGGGAGTACCAGGCACAGGCCGCGATCGCCGCGCTGCACGCCGACGCGAGGACTGCCGACGAAACCGACTGGGTGCAGATCGTCGAGTGGTACGACGAACTCGTTGCCCTCACCGACAGCCCCGTCGCGCGCCTCAACCGTGCGGTGGCAGTGGGTGAGGCCGACGGGCCGCGTGCGGGTCTGGCGGCCCTGGCCGAGCTCGACCCGGCGCTGCCGCGCCATACCGCGTCGGCGGCATATCTGCACGAACGTGCCGGCGACATCGCGCGTGCTGCCCAGCTGTACGTCGAAGCGGCCGACCAAGCGCATACCGTGCCGGAGCGAAATCACCTGCTGCTCAAGGCCGCCACGTTGCATCAGCGCCTCGGCTCACCGGGAGATGCAAAGAGGCTCCCGGGGTGA	MDPAALRDLIPGVLAALVRRGVDFATAEDAVQEALIKALETWSTGRAPDDPKAWLITTAWRRFIDVARAEAARRSRELRTAVEDPQGPTVPVDDTLQLYFLCAHPSLSPASAVALTLRAVGGLTTRQIARAYLVPESTMAQRISRAKRTVSEVRLNRLGNLGTVLRVLYLVFNEGYTGDVDLSAEAIRLARQLAAATDAPEVAGLLALFLLHDARRPARTRADGTLVPLAEQDRTLWRHDLITEGVAVLQAALAADRLGEYQAQAAIAALHADARTADETDWVQIVEWYDELVALTDSPVARLNRAVAVGEADGPRAGLAALAELDPALPRHTASAAYLHERAGDIARAAQLYVEAADQAHTVPERNHLLLKAATLHQRLGSPGDAKRLPG	MNIDEMVAEVLSSKKYTSVDPAVVRRVCMETAPKYPKKKEAIKAVKNELHIIHEVFLQNECYKNALSFLSQLSLDFNNAQLIDITMQIMQSHTSTKERLGDIEAVCSFLSTHISKEGSVMDIGCGFNPFALPLLHEFPATYYAYDICSEGINILNKYFSILKKGEYRAELLDAVSVTPKEKVDVALLFKLLPLLQQQKKGRGFSILEELDFDKAIVSFPIKSLGGKQKGMETFYSNLFEENLPSSLEIIEKQTFSNEMFYVIQNKTKNGGNQS	143.22	gnl|BL_ORD_ID|2252|hsp_num:0	3377			417	507	amikacin; gentamicin A; gentamicin
BGC0000365.1|Glycopeptidolipid_23 # 40546 # 42381 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	BGC0000365.1|Glycopeptidolipid_23 	40546	42381	-	Loose	600	27.7202	BKC-2	35.71	3006223	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	BKC Beta-lactamase	GTGAGCCACTACAAGAGCAATGTCCGTGATCAGGTATTCAACCTGTTCGAGGTTTTCGGTGTGGACAAGGTGCTCGGCGCTGACAAGTTCAGCGACCTGGATGCCGACACCGCCCGCGAGATGCTCACCGAGATCGCGCGCCTGGCCGAGGGCCCGATCGCCGAATCCTTCGTCGAGGGTGACCGCAATCCCCCGGTGTTCGATCCCGAAACCCATACCGTCACGCTGCCCGAGGGCTTCAAGAAGTCGATGCGTGCGCTGTTCGACGGCGGCTGGGACAAGGTCGGCCTCGCAGAGCACCTCGGCGGCATCCCGATGCCGCGTGCACTGCAGTGGGCCCTGATCGAGCACATCCTCGGCGCCAACCCTGCGGCCTACATGTACGCCATGGGCCCGGGCATGAGCGAGATCTTCTACAACAACGGCACCGACGAGCAGAAGAAGTGGGCCACCATCGCCGCCGAGCGCGGCTGGGGCGCCACCATGGTGCTGACCGAACCCGACGCGGGCTCCGACGTCGGCGCGGGCCGCACCAAGGCAGTTCAGCAGCCTGACGGCACCTGGCACATCGAGGGTGTGAAGCGATTCATCACCTCGGCCGACTCCGACGACCTGTTCGAGAACATCATGCACCTGGTGCTGGCCCGCCCCGAGGGCGCCGGACCGGGCACCAAGGGTCTGTCGCTGTTCTTCGTGCCGAAGTTCCACTTCGACCACGAGACCGGTGAGATCGGTGAGCGCAACGGCGTTTTCGTCACCAACGTCGAGCACAAGATGGGCCTGAAGGTCTCGGCCACGTGTGAGCTGTCGCTGGGTCAGCACGGCATCCCCGCCGTCGGCTGGCTGGTGGGCGAGGTGCACAACGGCATCGCGCAGATGTTCGACGTGATCGAGCAGGCGCGAATGATGGTGGGTACCAAGGCCATCGCCACGCTGTCGACCGGTTACCTCAATGCGCTCGAGTACGCCAAGGAGCGTGTCCAGGGCGCCGACATGACGCAGATGACCGACAAGACCGCACCGCGCGTGACCATCACGCACCACCCGGATGTGCGTCGCAGCCTGATGACCCAGAAGGCCTACGCCGAGGGTCTGCGTGCGATCTACCTGTACACCGCGACCTTCCAGGACGCCGAGGTGGCCCAGGCCGTGCACGGCGTCGACGGCGACCTCGCCGCACGCGTCAACGATCTGCTGCTGCCGATCGTCAAGGGCTTCGGCTCGGAGACCGCCTACGCCAAGCTCACCGAGAGCCTGCAGACCCTCGGTGGTTCCGGCTTCCTGCAGGACTACCCGATCGAGCAGTACATCCGCGACTCGAAGATCGACTCGCTGTACGAGGGCACCACTGCCATCCAGGCGCAGGACTTCTTCTTCCGCAAGATCATCCGTGACAAGGGTCAGGCACTGGCCTACGTCGCGGGCGAGATCGAGCAGTTCATCAAGAACGAGAACGGCAACGGCCGCCTGAAGACCGAGCGCGAACTGCTCGCCACCGCGCTCGCCGACGTCCAGGGCATGGCCGCTTCACTGACCGGCTACCTGATGGCCGCGCAGGAGGATGCCGCCTCGATCTACAAGGTGGGCCTCGGCTCGGTCCGGTTCCTGATGGCGGTCGGCGATCTGCTGTCCGGCTGGCTGCTGGCACGCCAGGCCGCGGTGGCCATCGAGAAGCTCGACGCAGGCGCCACCGGTGCCGACAAGTCCTTCTACGAGGGCAAGATCGCCGCGGCGTCGTTCTTCGCCAAGAACATGCTGCCGCTGCTGACCAGCACGCGCCAGATCATCGAGAACCTCGACAACGACGTCATGGAGTTGGACGAGGCGGCGTTCTAG	MSHYKSNVRDQVFNLFEVFGVDKVLGADKFSDLDADTAREMLTEIARLAEGPIAESFVEGDRNPPVFDPETHTVTLPEGFKKSMRALFDGGWDKVGLAEHLGGIPMPRALQWALIEHILGANPAAYMYAMGPGMSEIFYNNGTDEQKKWATIAAERGWGATMVLTEPDAGSDVGAGRTKAVQQPDGTWHIEGVKRFITSADSDDLFENIMHLVLARPEGAGPGTKGLSLFFVPKFHFDHETGEIGERNGVFVTNVEHKMGLKVSATCELSLGQHGIPAVGWLVGEVHNGIAQMFDVIEQARMMVGTKAIATLSTGYLNALEYAKERVQGADMTQMTDKTAPRVTITHHPDVRRSLMTQKAYAEGLRAIYLYTATFQDAEVAQAVHGVDGDLAARVNDLLLPIVKGFGSETAYAKLTESLQTLGGSGFLQDYPIEQYIRDSKIDSLYEGTTAIQAQDFFFRKIIRDKGQALAYVAGEIEQFIKNENGNGRLKTERELLATALADVQGMAASLTGYLMAAQEDAASIYKVGLGSVRFLMAVGDLLSGWLLARQAAVAIEKLDAGATGADKSFYEGKIAAASFFAKNMLPLLTSTRQIIENLDNDVMELDEAAF	MTITFSRRQAIAGALLAVPAVFTLAASAGAATGGLLEKRLAASAGAATGGLLEKRLAELEGRHKGRIGVAIHNLATGARIGHRADERFLMCSTFKALLAAHILARVDRKEETLDRRIVVGKSDLVDWSPVVETRVGGEGISIAELCEAAITLSDNAAANLLLSASGGPKAVTQFLRGFGDDVTRLDRTEPTLNYRETPDDERDTTTPAAMAETLRKLIIGDVLARGSKAQLAAWLVMNKTGDTRLRAGFPVDWTTGDKTGTNGDRHGNANDVAIAWSPDRGAVVVTAFCEIPGISGDERNAVIAEIGRIAAEA	195.21	gnl|BL_ORD_ID|3300|hsp_num:0	4369			534	657	
BGC0000365.1|Glycopeptidolipid_25 # 43718 # 54745 # -1 # ID=1_25;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0000365.1|Glycopeptidolipid_25 	43718	54745	-	Loose	750	114.005	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	27.88	3003463	protein variant model	G387D, G269S	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	TTGATCTTCCGGCGCGACATGTCCCCGCAAGGTCACATCGTCGCCGCCGATTCTAGGGAGGACAACGGCATGGTCTCTGCCGAACATCCGATCGAGCCGACCCCGAGCTTCGCAATCATCGGCTACGCCGCACGTTTTCCCGGCGCGGCGAGCGCCGAGGAATACTGGGCGTTGTTGCGGGACGGGCGTGAAGCGATATCCGATGTTCCGAAAGACCGCTGGGACATCGAGGAGTTCTTCGACCCGGACCCGTCGACACCGGGCAAGGTCGTCACGCGCCGCGCGGGGTTCGTCGATGACGTAACGGGTTTCGACGCGCCGTTCTTCGGTATGTCCGCCCGCGAGGTACGTCTGATGGACCCGCAGCACCGGATTCTCATGGAAACCGCGTGGCGCGCGGTCGAACACTCGGGAATCGCGCCGACGTCGCTGGCCAACAGCAACACGGGCGTCTTCGTCGGCCTGGCCACCCACGACTACCTCGGTATGGCCTCCGACGAACTCACCTACCCCGAGATCGAGGCCTACATGGCCATCGGAACCTCCAATGCCGCTGCGGCCGGACGGATCAGTTACCGCCTGGGATTGCAGGGACCGGCGGTGGCGGTCGACACCGCGTGCAGTTCGTCGCTGGTGGCGATTCACCAGGCGTGTCAGGCACTTCGCCTGAACGAGTGCGATCTCGCGTTGGCCGGCGGGGCGAACGTCCTGCTCACCCCGGCCACCATGATCACGTTCTCCAACGCGCACATGCTGGCTCCGGACGGCCGGTGCAAGACCTTCGACGCGGCGGCCGACGGCTACGTGCGCGGCGAGGGCTGCGGTGTCGTCGTGGTCAAGCGCCTCGAGGACGCGGTGCGCGACGGCGACCGGATCCGCGCGGTGATCCGCGGAAGCGCAATCAACCAGGACGGGGCGTCGGGCGGGCTGACCGTGCCGAACGGCGTTGCTCAGCAACGGGTTATCGCCGACGCGTTGAAGCGCGCCGGCCTGCGACCGGCCGATGTCGGTTATCTCGAGGCGCACGGCACCGGAACCTCACTTGGCGACCCCATCGAGGCCCAGGCCGCGGGCGAGGTGCTCGGGGCCGGACGCGCACCTGAAGAACCGCTGCTGATCGGCTCGGCGAAGACCAACATCGGCCATCTGGAAGCGGCCGCGGGCATCGCCGGTGTCATCAAGGTGGTCATGGCGCTCGAGAACGAGACGTTGCCCAAGCACCTCAATTTCGAGACTCCGTCGCCCCACATCCCGTGGGAGCGTCTACCCATCGAGGTGGTGAGAGAGACCGTTCCCTGGCAGCGCAACGGCAAGCCGCGGATCGCCGGGGTGAGCTCATTCGGGTTTGCCGGGACTAACGCGCACGTCATCCTCGAAGAGGCGCCCGCCGTCGGAACACCGGCGACGACAGAGCCTGTCGAGGATCCGAGGCGCTACAGCGTCCTTCCGCTGTCGGCACGCACGCCCGAGGCGTTGGTCCGACTCGCCGGTGAGTACCGCGACTGGCTGCGCGCCCACCCGCAGGCCCGCCTGGCCGACGTGTCCCACACCGCGGGAACCGCACGTGCCCACCTGGAGCAGCGTGCCGCGTTGGTGGTCAACTCGCGGGAATCGGCCATCGAACTGCTCGGCGCGCTCGCCGACGACCGTCCGGCGCCCGGCCTGGTCCGCGGTGAATCCCACGAGGCACCCAAGACCGCGTGGTTGTTCACCGGCCAGGGCAGCCAGTACCCCGGAATGGCGCGTGAGTTGTTCGACACCGAACCGGTGTTCGCCGAAACCGTGAGGAAATGCGCCGAGGCCGTCGCAGATATCCTCGAAAAGCCTTTGCTCGACGTCATTTTCGACGCCGACGAGTTGGATGGTGACACCGAATCGCCGCTGCGGCACACGACCTATGCGCAACCCGCGCTGTTCGCCGTCGAATTGGGCCTGGCCCGGCTCTGGCAGTCCTGGGGCTTCGAACCCGACGTGGTGGTCGGACACAGTGTCGGGCAGTACTCGGCCGCCTGTGTGGCGGGTGTGTTCGACGTCGAGGACGGCGCACGACTGATCGCCGAGCGCGGCCGATTGTTCGGCAGCCTGCCCGCGGGTGGACGCATGGCGGCGGTTTTCACCGCCCCCGAGCGTGCAGAGCGCCTCACCGACGAGTACCCCAGCCTGTCGGTTGCCGCGTACAACGGTGCCAACACCGTATTGTCCGGTCCCGCAAAGGATCTCGAATCCGCCGTGGCCACATTGGTGGCCGACGGTGTGCGGTGCGACTGGCTGGACACCAGCCACGCCTTCCACTCGGCACTGCTCGACCCGATTCTCGACGATTTCGAGTCGTTCGCCCAGAAGCTCGAATACCGTGAACCGCAACGTATCCTGATCGACAACCGCACCGGGTCCGCGCTCGGGCGGAGCACCAGGCTCGACGGTGCCTACTGGCGGCGGCACGCACGCCAGCCTGTCGAGTTCGCCAAGAGCGTCCGCACCCTCGCCGACATGAACTGCAGGGTGCTGCTGGAGATAGGGCCCAGGCCCGTGCTCACCGCCACCGCGCTGGCAGCATGGCCCGACCCGGCCACCACGCCGCAGGTGCTCGCGTCGCTGCGGCCCACCACGGCCGATCACCGGCAGATCACCGAGGCCGTCGCCGCCGCCTATGCCGCGGGACATCTGCCCGATTTCCGCGCGTTCCGGCAACCGGACGCGCGCAAACTCGACCTGCCCACATATCCCTTCGAGCATCGCCAGTTCTGGTTCTCGGACAACCGTGCGATCGACCGTGACACCCAGACCGCGAGCGCCGGTTCCGTCACGCCTCACCGCACACAGGCCGTCCGACTTCTCGAAGACGGCCAGATCGAGGAACTCGCCGCCCTCATCGACGGCGAGACCGTCGACGAGCAGACCCTGCGCGTGCTGAACAAGCTCGCGGCGCGCCACAACCAGCAGCGGTCCACACACGTCGACCCTGATGCGCGGTACGAGATCCGTTGGGACGCGATCGCTTCGGCCGCCGCGAGCACGGGCGCGGCAGCCGACTGGATCCTGGTCGGCGACGACACCGCTGCCGTCCTGGAGTTCGCCGATGCGCTCACCGCAGGCGGTCATCGCCACCAGATCGTCGCGCTGCCCGGCTCCGACGCCGACGAGGCCCAGCTGGTCGATACGCTGCGCGCTGCGTCGGCCGGTGAGCTGTACGTCGTGCACATCGCGGCAGGAGACGGTGCCGCTGCCCCGATGCGGGACCTGCTGCGCGTGCAGCACCGAACCCTTGGTGGGCTGCGGCGCCTGTTCCGCGCCGCGAACGACGCGGAACTGCGCAGCCCCATCTGGTTGGTGACACGTGACGGGCAGCGGGTCACCGACACCGACACCGTTGTGCCGGAACAGAGTTGCCTGTGGGGATTCGGCCGCGCGGCGGCCCTGGAACTCCCGCACATCTGGGGTGGCCTCGCCGACCTCTCCGGTGCGGACACCGAGTGGCCGCGGCTCATCGCGCGGATCACGTCACCGCGCGACGGTGAGGACCAGATCGCGCTGCGCGGGGACGCCGTGTACGCACCCCGACTGGTCCGCCGGACCGGCGAGCCGAGCGACACCCCCCTGCCGGTGCGGGAGGACCGCACCTATCTGGTGACGGGCGGTCTCGGGGCGATCGGGCTCGAGGTCGCCGGCTACCTGGCCTCCCACGGTGCCGGTCATGTGGTGCTCACCAGCCGACGGGAACCGGGCGACGACGCGCGCCGGCGCCTCGACGGTCTCCGCGAGCAGTACGCATGTGACGTCCGGGTGATCACCGCCGATGTCGCCGACGCGCACGACGTCGCGCGCCTCATGACCACCGTCGCCGCCGAACTCCCGCCGCTGGCCGGCATCGTGCACGCCGCGGGCGAGATCGGCACCACGCCGCTGAGCGGCCTCGACGACGCCGAGGTGGATCGCGTCTTCGCCGGGAAGGTCTGGGGCGCCTGGCATCTGAGCGAGGCCCTGACAGATCTTCGCACCGATCTCGACTTCTTCGTCAGCACATCGTCGATCGCGTCGGTGTGGGGCGGATTCGGGCAGACCGCCTACGGCGCGGCGAACGCGTTTCTCGACGGTCTGGCGTGGCGACTGCGCGAGCGGGGTGTCACCGCTGTCAGCGTGAACTTCGGGCCGTGGGCCGCGGGCATGGCCGACGCCGAATCACGTGCCCGCCTCGAGCAGCGAGGCGTGCGGACGTTGTCGCCCGCCGAGGCCCTCGCAGGCATGGCCGACGTCGTGGCCGGCCCCGTTCAGGGAGTCGTCGCCAAGATCGACTGGTCACGTTTCCTGCCGCTGTACCAGCAGGCAGGCCGGCGCGCGTTCCTGTCGGAACTCGAAAGCGAATTGCCCGCAGCGGCAACCGGCGCTGCTGCGCCCGCGACGGTGCCCGGGAAACCACCGCTCGTCGAGCAGTTGACCAAAGCGCCTGTGCAGCAACGCAAAAGCCTCATCACGAACTACCTGCGCAACGCGGTCGCCGAGGTCACACGGGTCGACGCCGACGAGATCCGCGATGAGGCCGGGTTCTTCGACCTCGGGATGGACTCCCTGATGGCCGTCGAACTGCGGCGGCGCATCGAGCAGGGTGTCGGCAAGGACATTCCCGTCACGCTCGTGATGGATCATCCGCGGTTGTCCGACGCGGCCGACTACCTGCTGGTCGAGGTACTCGGGTTGGGCGAGCAGACCAACGTGCGGCAGGCGTCGACCGTGACCGCGCGAACCGACGATCCCATCGCGGTCGTCGCGGTGTCCTGCCGCTTCCCCGGCGCACCCGACCCGGAGTCGTTCTGGGAGCTGCTCGCCGGTGGTGTCGATGCCATCCGAGAGGTCCCCGAGGACCGCTGGGACATCGACGAGTTCTACGACCCCGATCCGGACACCCCGGGCAAGACCTACACGCGGTTCGGCGGATTCCTCGACGGCATCGACGGATTCGATCCCGAGTTCTTCGGCATCTCACCGCGTGAGGCCGTGTGGATCGAGCCGCAGCAGCGCCTCATGCTCGAGACGGTGTGGGAGGGTCTCGAGCGGGCCGGCTACGCACCTTCGGACCTCCGGGGCAGCCGCACGGGTGTCTTCACCGGTGTTGCCGCCAACGAGTACGCGCATCTGCTGTCGGCCGAGTCGATCGACAAGATCGAGCCGCACTTCATCACGGGCAATGCGCTCAACGCGATCTCCGGTCGCGTGGCGTTCGCGCTGGGCTTCGAAGGTCCTGCCGTCGCGGTCGACACCGCGTGCAGCTCGGCTCTGGTCGCGGTCCATCAGGCATGTCAGGCACTGCAGTCCGGGGACTGCGATCTGGCCCTCGCGGGAGGCGTCAACGTGCTGCTGAGCCCCGTCACCGTGGTCGCGGCCTCACGCGCGCGGATGCTGTCGCCGGTGGGCCGGTGCAAGACGTTCGACGCGTCCGCCGACGGGTATGTGCGCAGTGAGGGCTGCGGCGTCCTGGTGCTCAAGCGCCTCAGCGACGCCGTGCGTGACGGCGACCGGGTGTGCGCGGTGATCCCTGCGAGCTCGGTGAACCAGGACGGCGCCTCCAGCGGGTTGACCGTCCCCAACGGCGGTGCGCAGCAACGGCTCATCGAGGCGACGCTGGCCCGCGCCGGACTGAGCGGCGCCGATGTGGACTACCTCGAGGCACACGGCACGGGTACGCCCCTCGGTGACCCGATCGAGGTGCAGGCCGCCGCGGCCGCGTACGGCGCCGGGCGTGACGCCGACCGGCCGCTGCTGATGGGATCGGTGAAGACCAACATCGGGCACACCGAATCCGCCTCGGGTGCAGCGGGTCTGATCAAGGTGGTGCTGTCACTGCAACACGGGGTGCTGCCGCAGAGCCTGCACTTCGAGAATCCGTCACCGCACATCCCGTGGGACGCATTGCCGGTGCGGGTGATCGACGAACCGGTGCCGTGGCAGACCAACGGCCGGGTGCGCCGTGCCGGTGTCAGTTCGTTCGGGTTCACCGGCACCAACGCGCACGTGCTCGTCGAGGAGGCCCCGCCGCAACTGCACACCGCCGACGCTGCGCCCGTGGAACCGGCCGCCACCGCGGAGGCCGGGACCGACGACTCGCCGCAGGTGCTGGCGCTGTCGGCGCGGTCGCCCGAGGCGCTCGTGGAGTTGGCGCGGCGCTACGACGACTGGTTGAGCGCGACGCCCGGCCTCGACATCGCCGACGTGTGCCACACCGCGGGCGTGGGCCGTTCGCACTTCGAATACCGCGCAGCCCTGGTGGTCGACTCGGTCGAGCGGGCACGCGAGGGTCTCGCCGCGCTCGCCGAGGGGCGCACTCCTGCGGGCGTGGTGCGCGGCGAGCATGTGCACCGTCCGACGACGGCATGGCTGTTCACCGGACAGGGCAGCCAGTACCCGGGCATGGCCCGCGAATTGTTCGACACGCAACCGGTTTTCGCCCAGACCGTTCGGCAGTGCGCCGAGGCGGTCGCCGACATGCTGCCGCGACCACTGCTGGACGTGCTGTTCGCGACCGACCGCGAAACCGCGGACCTGCTGCAGCACACGTCGTTCGCGCAGCCCGCGCTGTTCGCGGTCGAGATGGGTCTGGCGCGGCTGTGGCAGTCATGGGCCATCGAACCCGATGTGGTGCTGGGGCACAGCGTCGGCCAGTACGCCGCGGCCTGCGTGGCGGGCGTGTTCAGCCTTGACGACGGCGCACGACTGATGGCCGAGCGCGGCCGCATGTTCGGCAGCCTTCCCGAAGGCGGCCGGATGGTGGCCGTGTTCGCCGACGCCGAACACGTCGAGCAGGTGGCCGGTGAGTTCCCCCGGGTGTCGGTCGGCGCCTACAACGGCCCCAACACCGTGCTCTCGGGTCCCGGCGAGGACCTCGAAGAGATCGTCGAGAGGTTCGAGGACGAGGGGATCCGCTGCACGTGGCTGGCGACCAGCCACGCGTTCCACTCCGAACTGCTCGATCCCGTGCTCGACGAGTTCGAGGCCTACGCGGCCCAGTTCCAGTTCGCAGCGCCGACACTGCCTTTGGTGTGCAACCGGACCGGGGCCGTGCTCACCGGGCAGACCCCGCTCGACGCGCAGTACTGGCGCAGGCATTCCCGCCAGCCCGTGCAGTTCGCCGAGAGTGTGCGCACCGTCGCCGCGCTCGGCTGCTCGGTGCTGATGGAGATCGGCCCGCAACCTGTGCTGACCGGGGCCGCGGTACAGGTGTGGCCCGAACACATGGCTGCCCCGCGGGCCGTCGCCTCGCTGCGCAAGGGCGTCGCCGATCGCCGACAGATCGCCGATGCGCTGGCGTCGGCCTACGTCGGCGGCCACCGCCCCGACTTCGCCGCGGTGCACCGGCAGCCACGCCGCCCGGTCGAGTTGCCCACCTATCCGTTCCAGCGCCGCAGGTTCTGGCCGAAGGCCTCGAGCATCGCCGTCGACGGTGGGACCGCGGCGTCGGGAATCCTGGGCAGCGGCAAGGATCTGGCGTCCGGCGACACCATCTACACGAGCCGGCTGTCCGTCAAATCGCAGCCGTGGCTGGCCGATCACGTCATCTACGGCACCGTCGTCGTCCCCGGCGCGACGTATGCGGCGATGGCGCTCGCCGCGGTCGGCACACCGGCACGCCTGAAGGACGTGTTCTTCTACGAGCCGATCATCCTGCCCGAGAAGGCCTCTCGCGAGGTCCAGCTGACGTTGCACCCTGCCGACGGTGGCAGCGTGCTCAGCTTCCAGATCCACAGCCGCCCGTACGGTGAACGTGGTGCCGACTGGTCGCTGAACGCCGAGGGCACGGTCGACACGGCCGGCAGCGACCCGGACGCCGCCGCAGACGAGCAGTCGGATCCGGTCGACGAGGTGATCGAACGCCTCGAGCGCATGCGTCCGCAGGACCTCTTCGAGACCTTCGCCGACCTGGAACTGGCGTGGGGTCCCACATGGTCGGGCTCGCTGAAATCGTTGTGGCTCGGCGACGGTGAGGCCGTCGGCGACATCCTCGTCGGCGCCGAACTCGCCGAGCAACTCGGCTCCGAGCCCATGCACCCGGTGCTGATGGACCTGTGCACGGGCGTCGCGTTCCCCGCGTTCCCGGCGCTGCTCGCGGCCGAACAGGGCGTCAACGACCTGTTCCTGCCGCTGCGCTACGGGCAGGTGACGCTCGCGGAGAAGATGCCGCGGCGGTTCTACTGCCGGGCGAGGTGGCACCGTAGCGCGCTCGACAGCGAAACGCAGGTGTTCGAACTCGAATTCGTCGACCTCGGTGGGCGAGCGCTCGGCGGCATCCGCGAGTTCACCGTCAAACGTGCGCCGCGCGAGGCACTGCTGCGCGGCCTCGGGGGTGACGCGACCCGCCTGCTCTACACGCTCGGGTGGCACGAGGTGCCGCCGCCACCATCGGCCGACGACGCGGTCGGCACGTGGCTGATCGCCGGGTTCGACGAGCTGGCCGCGAAGGTGCCCGGCTGTGTCCCCATCGACCGCAACACCGATCTGCAGGTCCTCGGTGAGGTGCTGTCGCAGGCGCACGCTCGCGGCGCGGGATTCTCGGGCGTCGTGTGGCGTTGCGCGACGCCTGGCCGGAAGGAATCGGGTTCTGCCTCCGCCGAATCCGCCCGTCTGGAGGCCGAGATCACCAATCTGCTCAGCGCGGTGCACGCCGCGCAGGGGCCGAGCGTGAAACTGCCCGGCGGACTCTGGATCGTCACCGAACACGGCGTGGCATGTGAATCCGGCGAGCCGGTGGACCCGGTGCAGGCCGCGCTGTGGGGCTTCGGCCGAACGACGATCAACGAGGAACCGGCGCTGCACTGCCGGCTCGTCGACTGCGACGGATCTTCCGAGGCCGTCGACCTGCTGGCCGCTCTGCTGGCCGCACCGGGCATCCAGGAACCGGAAATCGCCGTGCGGCAGGGCAAACTGCTGGCGTCACGGTTGTTGCCGTGGGCCCGCAGTGGTCATCTCACGCTGCCGCGCGGGGGCGACTTCGTCCTTGCGCCCACCGAGCGCGGCGCGATCGACAACCTGCGCCTCACGGAGACGGACGTGCCGGAGCCGGACGAGGGCTACGTGCAGGTTCGGGTCGAGGCCGCGGGCCTCAACTTCCGCGACGTGCTCAACGTGCTCGGCCTGTACCCCGGTGATCCGGGACCGATCGGCGGCGACTTCGCAGGCACCGTGACCCAACTGGGGGCAGGTGTGAGTGGACTCGAAATCGGCCAACGCGTGTACGGGTCGATGCAGGGTGCCTTCGCGAGCCGCTTCAACGTGCCCGCCCAGTTCCTGGCGCCGATTCCCGACGGCATCGGCGCGGTCGAGGCCGCCACGATCCCGGCCGCGGCGCTGACGGTCCGGCTCGCGTTCGACTGGGCGCAACTCAAACCCGGCGACAAGGTGCTCATCCACGCCGCCAGCGGTGGCGTGGGGCTCGCGGCCATCCAGATGGCGCAGCAGTCCGGCGCCGAGGTCTTCGCCACCGCGAGCACCTTCAAGCGTTCGACCCTGCGCAGGCTGGGCGTGAAGTACGTCTACGACTCTCGGACGACGGACTTCGCCGACCAGATCCTCGCGGACACCAACGGTGCCGGCGTGGACGTGGTGCTCAACAGCCTCACGAGCGCGGGTTTCGTCGAGGCGACGCTGAAGGCCACCGCGCAGGGCGGACGCTTCGCCGAGATCGCCAAGCGCGACATCTGGTCGCATGAGCAGATGGCCGAGGCCCGCCCCGACATCGCCTACGAGATCGTCGCGCTGGACACCGTGATGTTCACCGAGCCCGATCGCATCCGCGACCTGCTCACCGAGGTGTCCGACGGGATGGCGCGCGGCGAGTGGACACCACTACCCGCCGAGATCTACCCGATCACCGAGGCCCGGTCGGCGTTCCGGCGCATGCAACAGGCACGGCACATCGGCAAGATTGTGCTGCAGGTCCCCAAACCCCTTCAGCCGCAGCAGGACCGGAGCTACCTGATCACCGGCGGACTCGGGGCGATCGGCCTGCACACGGCGGCGTATCTGGCGCAGCTCGGCGCGGGCGACATCGTGCTGACCAGCCGGCGCGACCCCGACGAGTCGGCCCAGCGGGCGATCGACGAGATCACCGAGCGCCACAAGTGCCGCATCCACACCTATGCGGCCGATGTGGGTGACGAGGCACAGGTGGCCGATCTGCTGGCGCGGATCCGGGCCGAGTTGCCTCCACTGGCCGGAATCGCCCATCTGGCGGGCGTGCTCGACGACGCGCTGCTGTCGGCGCAGAACCCCGAGCGCTTCCGGACCACGTTGGCGCCCAAGGCCTATGGCGCGAGCCACCTGGACCGCCTGACGCGCGACGACGACCTGGACTTCTTCATCGTGTCCTCGTCGGTGTCGAGCCTGTTCGGATCACCGGGGCAGGCCAACTACGCAACCGCCAATGCGATGCTCGACGGTCTGGTCGCCAAGCGCCGTGCGCAGGGCCTGGTGGCCACGGGCATCAACTTCGGGCCGTGGGGTCAGGGCGGCATGGCGTCGTCGGAGGCCGCGACCGCGAACATCACCGCCCAAGGTCTGATCCCGTTGGATCCGTCGGCCGCGTTGCACGCGCTGGCCGAGGTCATCGCGAACGGCTCCGGGCAGGCGACGGTGCTCAAGGCCAACTGGCAGCGCGCGGCGAAGGTTCTCGGCTCGGCGCGCCCGCCGATCCTGGACCTCGTCCTGCCGAGCGCGGCCGGGGAGGCCACGGGTGACAGCGAGCTGCTCAAGCAGTTGATGGAGATCCCGATACCGCAGCGCGCCGGGTTCGTCACCGAGTTCCTGCAACGCGAAGTGCAGAACTTCCTGCGTCTCGCGTCGCCGCCCGCGGCGTCGAGCCGGTTCCTGGACCTCGGCACGGATTCGCTGATGGCCATCGAGCTGCGCAACCGGCTGCACAGCCAGTTCGGGGGCAAGTTCACCATCAACGCGACCGCGGTGTTCGACTACCCGACCATCGGCGGGCTCGCGGAGTACCTCGTGGGTCAGCTGCCCGACGCCGAGGCGCCCGAAACGGCCTGA	MIFRRDMSPQGHIVAADSREDNGMVSAEHPIEPTPSFAIIGYAARFPGAASAEEYWALLRDGREAISDVPKDRWDIEEFFDPDPSTPGKVVTRRAGFVDDVTGFDAPFFGMSAREVRLMDPQHRILMETAWRAVEHSGIAPTSLANSNTGVFVGLATHDYLGMASDELTYPEIEAYMAIGTSNAAAAGRISYRLGLQGPAVAVDTACSSSLVAIHQACQALRLNECDLALAGGANVLLTPATMITFSNAHMLAPDGRCKTFDAAADGYVRGEGCGVVVVKRLEDAVRDGDRIRAVIRGSAINQDGASGGLTVPNGVAQQRVIADALKRAGLRPADVGYLEAHGTGTSLGDPIEAQAAGEVLGAGRAPEEPLLIGSAKTNIGHLEAAAGIAGVIKVVMALENETLPKHLNFETPSPHIPWERLPIEVVRETVPWQRNGKPRIAGVSSFGFAGTNAHVILEEAPAVGTPATTEPVEDPRRYSVLPLSARTPEALVRLAGEYRDWLRAHPQARLADVSHTAGTARAHLEQRAALVVNSRESAIELLGALADDRPAPGLVRGESHEAPKTAWLFTGQGSQYPGMARELFDTEPVFAETVRKCAEAVADILEKPLLDVIFDADELDGDTESPLRHTTYAQPALFAVELGLARLWQSWGFEPDVVVGHSVGQYSAACVAGVFDVEDGARLIAERGRLFGSLPAGGRMAAVFTAPERAERLTDEYPSLSVAAYNGANTVLSGPAKDLESAVATLVADGVRCDWLDTSHAFHSALLDPILDDFESFAQKLEYREPQRILIDNRTGSALGRSTRLDGAYWRRHARQPVEFAKSVRTLADMNCRVLLEIGPRPVLTATALAAWPDPATTPQVLASLRPTTADHRQITEAVAAAYAAGHLPDFRAFRQPDARKLDLPTYPFEHRQFWFSDNRAIDRDTQTASAGSVTPHRTQAVRLLEDGQIEELAALIDGETVDEQTLRVLNKLAARHNQQRSTHVDPDARYEIRWDAIASAAASTGAAADWILVGDDTAAVLEFADALTAGGHRHQIVALPGSDADEAQLVDTLRAASAGELYVVHIAAGDGAAAPMRDLLRVQHRTLGGLRRLFRAANDAELRSPIWLVTRDGQRVTDTDTVVPEQSCLWGFGRAAALELPHIWGGLADLSGADTEWPRLIARITSPRDGEDQIALRGDAVYAPRLVRRTGEPSDTPLPVREDRTYLVTGGLGAIGLEVAGYLASHGAGHVVLTSRREPGDDARRRLDGLREQYACDVRVITADVADAHDVARLMTTVAAELPPLAGIVHAAGEIGTTPLSGLDDAEVDRVFAGKVWGAWHLSEALTDLRTDLDFFVSTSSIASVWGGFGQTAYGAANAFLDGLAWRLRERGVTAVSVNFGPWAAGMADAESRARLEQRGVRTLSPAEALAGMADVVAGPVQGVVAKIDWSRFLPLYQQAGRRAFLSELESELPAAATGAAAPATVPGKPPLVEQLTKAPVQQRKSLITNYLRNAVAEVTRVDADEIRDEAGFFDLGMDSLMAVELRRRIEQGVGKDIPVTLVMDHPRLSDAADYLLVEVLGLGEQTNVRQASTVTARTDDPIAVVAVSCRFPGAPDPESFWELLAGGVDAIREVPEDRWDIDEFYDPDPDTPGKTYTRFGGFLDGIDGFDPEFFGISPREAVWIEPQQRLMLETVWEGLERAGYAPSDLRGSRTGVFTGVAANEYAHLLSAESIDKIEPHFITGNALNAISGRVAFALGFEGPAVAVDTACSSALVAVHQACQALQSGDCDLALAGGVNVLLSPVTVVAASRARMLSPVGRCKTFDASADGYVRSEGCGVLVLKRLSDAVRDGDRVCAVIPASSVNQDGASSGLTVPNGGAQQRLIEATLARAGLSGADVDYLEAHGTGTPLGDPIEVQAAAAAYGAGRDADRPLLMGSVKTNIGHTESASGAAGLIKVVLSLQHGVLPQSLHFENPSPHIPWDALPVRVIDEPVPWQTNGRVRRAGVSSFGFTGTNAHVLVEEAPPQLHTADAAPVEPAATAEAGTDDSPQVLALSARSPEALVELARRYDDWLSATPGLDIADVCHTAGVGRSHFEYRAALVVDSVERAREGLAALAEGRTPAGVVRGEHVHRPTTAWLFTGQGSQYPGMARELFDTQPVFAQTVRQCAEAVADMLPRPLLDVLFATDRETADLLQHTSFAQPALFAVEMGLARLWQSWAIEPDVVLGHSVGQYAAACVAGVFSLDDGARLMAERGRMFGSLPEGGRMVAVFADAEHVEQVAGEFPRVSVGAYNGPNTVLSGPGEDLEEIVERFEDEGIRCTWLATSHAFHSELLDPVLDEFEAYAAQFQFAAPTLPLVCNRTGAVLTGQTPLDAQYWRRHSRQPVQFAESVRTVAALGCSVLMEIGPQPVLTGAAVQVWPEHMAAPRAVASLRKGVADRRQIADALASAYVGGHRPDFAAVHRQPRRPVELPTYPFQRRRFWPKASSIAVDGGTAASGILGSGKDLASGDTIYTSRLSVKSQPWLADHVIYGTVVVPGATYAAMALAAVGTPARLKDVFFYEPIILPEKASREVQLTLHPADGGSVLSFQIHSRPYGERGADWSLNAEGTVDTAGSDPDAAADEQSDPVDEVIERLERMRPQDLFETFADLELAWGPTWSGSLKSLWLGDGEAVGDILVGAELAEQLGSEPMHPVLMDLCTGVAFPAFPALLAAEQGVNDLFLPLRYGQVTLAEKMPRRFYCRARWHRSALDSETQVFELEFVDLGGRALGGIREFTVKRAPREALLRGLGGDATRLLYTLGWHEVPPPPSADDAVGTWLIAGFDELAAKVPGCVPIDRNTDLQVLGEVLSQAHARGAGFSGVVWRCATPGRKESGSASAESARLEAEITNLLSAVHAAQGPSVKLPGGLWIVTEHGVACESGEPVDPVQAALWGFGRTTINEEPALHCRLVDCDGSSEAVDLLAALLAAPGIQEPEIAVRQGKLLASRLLPWARSGHLTLPRGGDFVLAPTERGAIDNLRLTETDVPEPDEGYVQVRVEAAGLNFRDVLNVLGLYPGDPGPIGGDFAGTVTQLGAGVSGLEIGQRVYGSMQGAFASRFNVPAQFLAPIPDGIGAVEAATIPAAALTVRLAFDWAQLKPGDKVLIHAASGGVGLAAIQMAQQSGAEVFATASTFKRSTLRRLGVKYVYDSRTTDFADQILADTNGAGVDVVLNSLTSAGFVEATLKATAQGGRFAEIAKRDIWSHEQMAEARPDIAYEIVALDTVMFTEPDRIRDLLTEVSDGMARGEWTPLPAEIYPITEARSAFRRMQQARHIGKIVLQVPKPLQPQQDRSYLITGGLGAIGLHTAAYLAQLGAGDIVLTSRRDPDESAQRAIDEITERHKCRIHTYAADVGDEAQVADLLARIRAELPPLAGIAHLAGVLDDALLSAQNPERFRTTLAPKAYGASHLDRLTRDDDLDFFIVSSSVSSLFGSPGQANYATANAMLDGLVAKRRAQGLVATGINFGPWGQGGMASSEAATANITAQGLIPLDPSAALHALAEVIANGSGQATVLKANWQRAAKVLGSARPPILDLVLPSAAGEATGDSELLKQLMEIPIPQRAGFVTEFLQREVQNFLRLASPPAASSRFLDLGTDSLMAIELRNRLHSQFGGKFTINATAVFDYPTIGGLAEYLVGQLPDAEAPETA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	883.41	gnl|BL_ORD_ID|1968|hsp_num:0	1943			75	1224	isoniazid
BGC0000365.1|Glycopeptidolipid_26 # 54786 # 56339 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.615	BGC0000365.1|Glycopeptidolipid_26 	54786	56339	+	Loose	300	28.1054	dfrA35	25.68	3005164	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGTGCGTCGTGTCGTCCGCCGTTCCGACCCTAGGGGCGGCCACCGACGGCCGGTCCGGAGTATGTTGTTCCCGCAGCGGCTCCAGCCGCGCCGGGGGCCGGCTGAACGGGAATTATTGGGAAGGACCACGTTTGCGAATCGGCAAGATCACGGTTGGCCCACTCGATGAATGGTCGCTCAAGCCGGGCACGGTCACTTCCTGGCAACCGACGGCCGCCGCGCGCGAAGTGGCGCGACAGGCGCCGGTCAGTTCGGTTCCCGTGAGCTACATGCAAGAGCAACATCTGCGTAACTTCTGCGAACGCACCGCCGCGGGATTGAATTTCTCCAGACAGATCATCGCGAGTTGTGAAGTACCGGGCCAATGCGACATTTCCGCGATGGATCACGCCGTCAACTCATACCTGCGAAGGCACGACACGTTCCGCAGTTGGTTCGAGGACGCGGGCGACGGGAAATTCATCCGGCATTCCATCGAGAACCCGGACGACATCGAATTCGTTCCTGTCGAACACGGTGCGATGTCGATCGACGAGATCCACGCCCATGTGACCGACATACCGACTCCGTTGGAGTGGGCATGCTTCACGTTCGGGGTCATCCAGAGCGAGGACCATTTCACGTTCTTCGCGGCCATGGACCACGTCCACGGCGACGCGACCCTGATCGGCACGACAATGCTCGAAGCCAACGGCATGTATTCGGCGCTCAGCGGCGGCGGCGAGGCGCTGGTTCTTCCCGAAGCGGGCAGCTTCGACGATTTCTGTATTCGAGAACGTGAACGCACCGCGGATCTGACCGTCGACTCGCCCGAGGTCCGCGCCTGGATCGAATTCGCGGAAGACAACAATGGCGGCTTTCCCGAGTTCCCGCTTCCGCTGGGGAATCCGAAGAAATCGACCAGTAGCGACATGACGTCGGAAATCCTGCTGGACCCCGCGCAGACGGAACGTTTCGAATCGGCATGCAACGCGGCCGGGGCGCGTTTTGTCGGTGGTCTTTTCGCGTGCCTGGCGCAGGTGGAACACGAGTTGACCGGTGCACTCACGTATTACGGGCTCACTCCGCGTGACTCGAGAAATGCCACCGACAATTTCATGACGCAGGGCTGGTTCACGGGTCTCATCCCTATCACCGTTCCGATCGGTGCGGCGTCATTCACCGAAGCCGCCGGATCCGCCCAGAGATCTTTCGACGCCAATCTGAACATGGCGAAAGTCCCGTATTACCGGGTGCTGGAGTTGGCCCCGTCGCTGCGGTGGCCGCAACCCAATTTCCCTGTGTCGAATTTCTTCCACGGTGGCGCCGCGCCACTCAACGCCGTTCTCGCCGCGGCCGACATGGGACTCGCGAACAACATCGGGATCTACCCCGACGGCCGCTACTCGTATCAGCTCACCATCTACATATTCCGGTATGGCGAGGGCACCGCCATGGCAATCATGCATCCCGACAATTCAGTCGCCAGAAAGTCGGCCACCCGCTACATGGAGACGATGCGCTCGGTAGCCGGTCAGGTGGCCGACAGTGGTAACTGGGGGCGCGTCGCATAG	MCVVSSAVPTLGAATDGRSGVCCSRSGSSRAGGRLNGNYWEGPRLRIGKITVGPLDEWSLKPGTVTSWQPTAAAREVARQAPVSSVPVSYMQEQHLRNFCERTAAGLNFSRQIIASCEVPGQCDISAMDHAVNSYLRRHDTFRSWFEDAGDGKFIRHSIENPDDIEFVPVEHGAMSIDEIHAHVTDIPTPLEWACFTFGVIQSEDHFTFFAAMDHVHGDATLIGTTMLEANGMYSALSGGGEALVLPEAGSFDDFCIRERERTADLTVDSPEVRAWIEFAEDNNGGFPEFPLPLGNPKKSTSSDMTSEILLDPAQTERFESACNAAGARFVGGLFACLAQVEHELTGALTYYGLTPRDSRNATDNFMTQGWFTGLIPITVPIGAASFTEAAGSAQRSFDANLNMAKVPYYRVLELAPSLRWPQPNFPVSNFFHGGAAPLNAVLAAADMGLANNIGIYPDGRYSYQLTIYIFRYGEGTAMAIMHPDNSVARKSATRYMETMRSVAGQVADSGNWGRVA	MISIVVAKSANHVIGVDNQLPWRLPSDLKWFKETTTGGVVVMGRKTFESIGKPLPDRINVIISKQPVPIEWASKVVWVNSIQQAMDYVRGLDGMIKTFIIGGSEIYRQFISLVDQVYLTEVGAEIEGDATFQPLDEHEWTLKTWWVVPDQSSKDQFRYQRKLYVRKVLDE	304.12	gnl|BL_ORD_ID|2871|hsp_num:0	3887			165	369	trimethoprim
BGC0000365.1|Glycopeptidolipid_27 # 56373 # 59381 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.662	BGC0000365.1|Glycopeptidolipid_27 	56373	59381	+	Loose	1900	40.4318	MuxB	25.98	3004074	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTAAGCTAGCCGATCTTGTGGTGCGGTGGCCCCTGGTGGTGATCGGGGTCTGGCTCGCGATGGCCGTCGCCCTGCCGCTGTCGTTCCCGTCCCTCGGCGAGATGGCCGAGAAGCACCCGCTGCAGGTCCTTCCCGCCGAGGCCCCCTCGAGCGTCACGGCCGCGAAAATGGCCGAGGCGTTCCAGGAATCGGGCAACGACGACCTGATGCTGGTCGCGCTGATCAACGACAAGGGCCTGACACCCGACGACGAGGCCGTCTACCGCAAGATCGTCGACGCACTGCGCGGTGATCTGATCAACGTGGTGTCGGTGCAGGACTTCATCGGCACGCCACAACTCCGGCCGTTTCTGACCAGCCAGGACAAGACCACCTGGGTGCTGCCTGTCAGCCTTGAGGGCGAACTCGGCACGCCGCGCGCCTTCGAATCGTTCAACCGCGTCTCAGAGATCGTCGAGCACACCGTCGACCAGAACGCCGCGGACGGCGCGCTGCAGGTGCACATCACCGGTCCGGCGGCGACCGTCGCCGACCTGACCGTCGCGGGCCAGCAGGATCGTCTGCCCATCGAGATCGCGATCGCGGTGCTGGTGCTCGGCGTGTTGCTGCTGGTGTACCGCAACGTCGTCACCATGCTCTTGCCTCTGGTGACCATCGGATCGTCGCTGATCATCGCGCAGTCCGTGGTGGCCGGCTATTCAGAGCTCACGGGATCCGGCGTCTCCAATCAGTCCATGGTGTTCCTCAGTGCCATCATGGCCGGCGCGGGGACGGACTACGCGGTGTTCCTGATCAGCCGCTATCACGACTTCCTGCGCTCGGGTCACGGTTACGACGAGGCGGTCCGTGCGGCCATGATCTCGATCGGCAAGGTGATCGCGGCGTCGGCCACCACGGTGGGGCTGACGTTCCTTCTGCTGAGTTTCGCCAAGATGGGCGTGTTCAGAACCGTGGGCGTCGCCGCGGCGATCGGCATCGCGGTCGCATTTCTCGCCGGCGTGACACTGCTTCCGGCGATTCTGGTGCTGGCCGGGCCGCGCGGCTGGGTCAAACCGCGCCGCGAACTGACCACGCGGTTCTGGCGCAGGTCCGGTATCCGCATCGTGCGTCGCCCGGTCCCACACCTCGTGGGCAGTGTGCTCGTGCTGGCCCTGCTGGGGGGCTTCACGCTCGTGGCGCACTACAACTACGACGACCGCAAGGTGGTCTCGCCGGACGCGTCGAGTTCAATCGGATATGCCGCGCTGGAGCAACATTTCCCCATCAGCCAGTCCATCCCCGAGTACATCTTCATCCAGTCGCCGCACGATCTGCGCAATCCGCGAGCACTCGCCGACCTGGAACAGCTGGCCTCACGCGTTGCGCAACTGCCGGACGTGGGCCTGGTCAGCGGCATCACCCGGCCGCTGGGCGAGGTGCCGCCGGAGTTCCGAGCGACGTTCCAGGCCGGCATCGTCGGTGACCGGCTCGCGGACGGTTCGACGCAGATCGACCAACGCACGTCCGACCTCAACCGGCTGACCTCCGGCGCGAAGACACTGGCCGACAGCCTCGCCGACGTGCGAAGCCAGATCAACCAGATCGCGCCCAGCATCCAGAGCCTGGTCGACACGTTCTCGTCGGTGCGCACCGAGTACGGCGGCGACAAGCTGGTTCGCGACGTCGACACCGCGGCCAAGCTCGTCGCGAGCGTCAACGCGCTCGGCAATGCCATGGGCATCAACCTCGCCGCGGTCAAGGACATGTTCGCGTGGATCGGTCCGGTCCTTGCGGCCCTGCAGGGCAACCCGGTGTGTGACGCCAATCCGTCGTGCTCGGCGACGCGCGCGCAGTTCGAGCGTGTTCTCGACCCCAGCAACGAAGGCAATCTCAACCAGATCAACCAACTCGCCCAGGAGTTCCAGGGCGTCGAGGATCGCGAGACCCTCAACTCGGCGGTGAAGAAGCTCAACGCCGCCATGGCGAATGTCGCCAAGGCCGTCGACGCCATGGGACTCGACAAACCCGGCGGCACGCAGAAGGGCCTGAAGGATCTGCAGCAGGGTGCCAGCCGTCTGGCGGGTGGCAGCCGAGAGGTGGCCGGCGGGGTCGACGAACTGGTCAAGCAGGTGAAGGTGATCGCCGCGGGCCTCAACGAGGCGTCGACGTTCCTGCTGACGATGCGCAACAACGCGGCCGACCCGTCGCAGGCCGGGTTCAACATCCCGCCCGAGGTGTTCGGGCTCGAGGATTTCAAGAAGGCCTCCGCGGCCTACATCTCACCGGACGGGCATTCGGTGCGCTATCTGGTGCAGACCAAGCTCAACCCGTTCAGCGCCGAGGCGATGGACCAGGTCAACCAGATCGGTGACATCGCGCGCGGCGCGCAGCCCAACACCACGCTGGCCGACGCCGAGATCTCGATGGGTGGGTTCCCCGTCGCCTTGCGGGACACGCGGGACTACTACCAGCAGGACATCCGGTTCATCATCATCGCGACGCTGATCGTCGTGTTGCTGACGCTGACGGTGCTGCTGCGCACGGTCATCGCCCCCCTGTATCTCGTGGGCTCCGTGGTGGTCTCGTACTTCGCCGCGATCGGCCTCGGTGTCCTGATGTTCCAGGTCGTACTCGGCCAGCAGTTGCACTGGAGTGTGCCGCCGCTGGCGTTCGTCGTCCTGGTGGCGGTGGGTGCCGACTACAACATGTTGTTCGTGTCGCGGCTACGCGACGAATCTCCGCACAGTGTGCGGTACGGCGTCATCCGCACCCTAGGTTCGACCGGTGGCGTGATCACCGCGGCGGGACTCATCTTTGCCGCGTCGATGGCCGGGCTGTTGTTCTCCAGCATCGGGCTCGTGGTGCAGGGCGGTTTCGTGATCGGGGTGGGAATCCTGCTGGACACCTTCGTGGTTCGGACCATCACGGTGCCCGCGATCGCTTCGCTGGTGGGCCGGGCGAACTGGTGGCCGGGGCAGATCGGGACATCGCCGTCGAACTCGCGGGCGCCGGCAGAGGTGACCTGA	MRKLADLVVRWPLVVIGVWLAMAVALPLSFPSLGEMAEKHPLQVLPAEAPSSVTAAKMAEAFQESGNDDLMLVALINDKGLTPDDEAVYRKIVDALRGDLINVVSVQDFIGTPQLRPFLTSQDKTTWVLPVSLEGELGTPRAFESFNRVSEIVEHTVDQNAADGALQVHITGPAATVADLTVAGQQDRLPIEIAIAVLVLGVLLLVYRNVVTMLLPLVTIGSSLIIAQSVVAGYSELTGSGVSNQSMVFLSAIMAGAGTDYAVFLISRYHDFLRSGHGYDEAVRAAMISIGKVIAASATTVGLTFLLLSFAKMGVFRTVGVAAAIGIAVAFLAGVTLLPAILVLAGPRGWVKPRRELTTRFWRRSGIRIVRRPVPHLVGSVLVLALLGGFTLVAHYNYDDRKVVSPDASSSIGYAALEQHFPISQSIPEYIFIQSPHDLRNPRALADLEQLASRVAQLPDVGLVSGITRPLGEVPPEFRATFQAGIVGDRLADGSTQIDQRTSDLNRLTSGAKTLADSLADVRSQINQIAPSIQSLVDTFSSVRTEYGGDKLVRDVDTAAKLVASVNALGNAMGINLAAVKDMFAWIGPVLAALQGNPVCDANPSCSATRAQFERVLDPSNEGNLNQINQLAQEFQGVEDRETLNSAVKKLNAAMANVAKAVDAMGLDKPGGTQKGLKDLQQGASRLAGGSREVAGGVDELVKQVKVIAAGLNEASTFLLTMRNNAADPSQAGFNIPPEVFGLEDFKKASAAYISPDGHSVRYLVQTKLNPFSAEAMDQVNQIGDIARGAQPNTTLADAEISMGGFPVALRDTRDYYQQDIRFIIIATLIVVLLTLTVLLRTVIAPLYLVGSVVVSYFAAIGLGVLMFQVVLGQQLHWSVPPLAFVVLVAVGADYNMLFVSRLRDESPHSVRYGVIRTLGSTGGVITAAGLIFAASMAGLLFSSIGLVVQGGFVIGVGILLDTFVVRTITVPAIASLVGRANWWPGQIGTSPSNSRAPAEVT	MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR	96.07	gnl|BL_ORD_ID|2364|hsp_num:0	2718			882	1455	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000365.1|Glycopeptidolipid_28 # 59491 # 61200 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0000365.1|Glycopeptidolipid_28 	59491	61200	+	Loose	1000	37.7354	almE	24.06	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCTGCACGGCCGTGCCAGCCTGCGTCCCGACGACATCGCGTTCACCTTCACCGACTACGACGGTGATCCGTCGGGCGTCGCGCAGAGCCTGACGTGGTCCGTGCTGGCGCGTCGAACGATCAACGTGGCCAGAGAGATCCGGCGCCACGGCGCCGTGGGGGACCGGGCTCTGATACTCGCGCCGCAGGGACTCGAATACATCCTCGCGTTCCTGGGATCGATGCAGGCCGGACTCATCGCGGTACCGTTGCCGTTGCCGCATCGGGGGTCGGGACACGACCGGGTGAGTGCGGTGTTCGCCGACACCGAGCCGACGGTCGTGCTCACGACGTCGGCAGCCGCCACCGACGTCGCCGAATTCGTCGCGTCGTCGCGCACCGATCCGGCGATCATCGAGATCGATTCGCTTGCTCTGGATTCCGACTACTCCGGCGCGGAAACCGATCTCGGTCCGGTCGGGCTGTCCGACATCGCCTACCTGCAGTACAGCTCCGGATCGACGCGGCTGCCGACCGGGGTCATGATCTCGCACCGCAACCTCACCGCGAACTTCGACCAGTTGATGCGGAGTTTCTTCGCCAGGTCGCCGCTTCCGCAGGATGCGACGCTCGTGTCGTGGCTGCCCTTCTATCACGACATGGGCCTGGTGCTGGGGGTGTGCGCGCCGATCCTGTGCGGGCGCCACGCACAGCTCACGAGCCCGGTGGCGTTCCTGGAACGTCCGGCCCGGTGGGTGCGGGCGCTCGCCGAGAATCCACACGCCTGGTCGTCGGCACCCAACTTCGCGTTCGACCTCGCGGCACGCAGGACCAGCGACGAGGATCTGGCCGGGCTGGACCTCGGCGGGGTGGTGGGCATCATCAGCGGCGCCGAACGCGTCGAATCGGCCACGCTGCGCCGCTTCGTGGACCGCTTCGCGCACTTCAACTTTCGTGACCACATGATGCGTCCCGCGTACGGGCTGGCGGAGGCCACGGTGTTCGTGGCCTCGGGCATCTGGGACGAGGATGCGCCGGCCGGGTACTTCGACGCCGAAGCGCTGAGCGCGGGCCGGGTCAGTCCCAGCGCGCCGCGCAAGGGCACCGCACTGGTGAGATACCAGGTGCCGCAGTCACCTTCGCTGCGAATCGTCGACGTCGACACGCGCCGCGAGACCCCGCCGGGTGTGGTGGGAGAGATCTGGGTGCACGGCGACAACGTCGCCTCCGGGTACTGGGGCAAACCGGCGGACGAGAGCACGTTCGGCGCAACACTTCTCGACCCGTCGCCGGGTACGCCCGATGGCCCGTGGCTGCGCACGGGTGACCTGGGGTTCGTCCATGCCGGCGAACTGTACGTCGTCGGACGCATCAAGGACGTCCTGATCATCCGGGGCCGCAACCACTATCCCGAGGATATCGAGGCCACGGTGCAGGCCATCACCCACGGCAGGGTGGCGGCCATCTCGGTTCCGGTGAACAGCACCGAGGAGTTGGTGACCGTCATCGAACTCAAGAAGCCGGCCGACCTCGACGCCGAGGCCATCCGTCGGTTCGGCGAGGTCAAGAGCAACGTCACCGCCGCGGTGGCGAACGCGCACGGCCTGAGCGTGGCGGATCTGGTTCTCGTGCCGTCGGGTTCGCTCCCGACCACCACGAGCGGCAAGATCCGGCGTGCGGCCTGTGCAGAGCAGTACCGGCAGAAGCAGTTCGTCAGGTTGGACGGCTGA	MLHGRASLRPDDIAFTFTDYDGDPSGVAQSLTWSVLARRTINVAREIRRHGAVGDRALILAPQGLEYILAFLGSMQAGLIAVPLPLPHRGSGHDRVSAVFADTEPTVVLTTSAAATDVAEFVASSRTDPAIIEIDSLALDSDYSGAETDLGPVGLSDIAYLQYSSGSTRLPTGVMISHRNLTANFDQLMRSFFARSPLPQDATLVSWLPFYHDMGLVLGVCAPILCGRHAQLTSPVAFLERPARWVRALAENPHAWSSAPNFAFDLAARRTSDEDLAGLDLGGVVGIISGAERVESATLRRFVDRFAHFNFRDHMMRPAYGLAEATVFVASGIWDEDAPAGYFDAEALSAGRVSPSAPRKGTALVRYQVPQSPSLRIVDVDTRRETPPGVVGEIWVHGDNVASGYWGKPADESTFGATLLDPSPGTPDGPWLRTGDLGFVHAGELYVVGRIKDVLIIRGRNHYPEDIEATVQAITHGRVAAISVPVNSTEELVTVIELKKPADLDAEAIRRFGEVKSNVTAAVANAHGLSVADLVLVPSGSLPTTTSGKIRRAACAEQYRQKQFVRLDG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	102.34	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1434	colistin A; colistin B
BGC0000365.1|Glycopeptidolipid_29 # 61262 # 62413 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.687	BGC0000365.1|Glycopeptidolipid_29 	61262	62413	+	Loose	500	26.1794	TEM-82	35.09	3000949	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGAGGAGACGACTTCTCGCGTTCGGCACGGCGTTCACCACGATCGGCACCGCGGGATTTCTCGGTTTCGGTGTCGCGGCTGCCGATGACACCAAACCGGTCGACCCGGCACCCGGCGGCGCCCACGCCGAGGCGCCATCGATGGGCACACCCGGACGCGGGTACGCGCTCGGGGGCGCGCACGTGCTGGGCATCCCGTACGACGAATACATCATGCGCACCGGCGCGGACTGGTTCCCCGGTCTCGACCGGCAGATCGTCGACTACCCGGCCGGGCAGGTGCAAGGCCACACCCTGGAGCGGCTGTTCCCGGGTATCGGTGCGCTCGGCGAGCGCTTCATGCCGGGCCTGGGTCTCGACGGTCCGAGTTACGGCGAATCGATCGACGTCGGCGCGCCCAACCTCATCAACGCGATCCGCCAGGGCGGCCCGGGAACGGTGATCGGCCTGTCCGAGGGCGCGTCGGTGCTCGACGAGGTGCAGGCGCGTCTCGCGTACGACCCGGCCGCGCCGCCGCCGGACAGCCTGAGCTTCGCGACGTACGGCAACCCCGTCGGCAAGCACGCCTTCGGCGAGAGTTTCCTGACGCAGATGTTCCCGGTCGGCAGCGTCGTCCCGTCGCTCGACTACCGCATCCCGGCTCCGGTGGAAAGCCAGTACGACACCTACCAGTTCGTCTCGGCATACGACAGCATCGCGGACTGGCCGGACCGGCCGGACAACTGGATCTCCGTCGCCAACGCGATCGTGGGCCTCGCGACCGGGCACACCGCCGTCGCGTTCACCAACCCGAGCATGGTGCCCCCACAGAACATCCGGACCACCGTCAACTCGCGCGGCGCGAAGGACACGACGATCATGATCCCCGAGGAGCACCTGCCACTGGTGTTGCCGTTCAAGTACCTCGGGGTGGACAAGGACACGCTGAACAAGCTCGACGGCGTGCTCAAGCCGTACGTGGATGCCGGCTACTCGCGCAACGACGATCCGCTGACCGCGCCCATCACGGTCGACCCGGTCAACGGGTACGACCCGGCGGCGGTCACGGCGCCGGCCACGCAGGCGGCCTTCGGCGGAGGTACCGACCCGGTGTCGCAATTGCTCGCCGGACTGCAGTACGTCGTGAACAATCAACCGGCGCCCAAGCCCTGA	MRRRLLAFGTAFTTIGTAGFLGFGVAAADDTKPVDPAPGGAHAEAPSMGTPGRGYALGGAHVLGIPYDEYIMRTGADWFPGLDRQIVDYPAGQVQGHTLERLFPGIGALGERFMPGLGLDGPSYGESIDVGAPNLINAIRQGGPGTVIGLSEGASVLDEVQARLAYDPAAPPPDSLSFATYGNPVGKHAFGESFLTQMFPVGSVVPSLDYRIPAPVESQYDTYQFVSAYDSIADWPDRPDNWISVANAIVGLATGHTAVAFTNPSMVPPQNIRTTVNSRGAKDTTIMIPEEHLPLVLPFKYLGVDKDTLNKLDGVLKPYVDAGYSRNDDPLTAPITVDPVNGYDPAAVTAPATQAAFGGGTDPVSQLLAGLQYVVNNQPAPKP	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDEQNRQIAEIGASLIKHW	133.92	gnl|BL_ORD_ID|1726|hsp_num:0	1868			177	321	ampicillin
BGC0000365.1|Glycopeptidolipid_31 # 63131 # 64156 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697	BGC0000365.1|Glycopeptidolipid_31 	63131	64156	+	Loose	525	28.8758	OKP-A-14	46.15	3002431	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OKP beta-lactamase	ATGCCGATCCGGACGCTGGCCGTGGCGGGCCGTCTGCCCGATGATGGCGGGGTGACTGCTCTGAGCACCGCATTGCCTGTCGTGGATCTCGGTGACGACGCTGCAGTGGTGACCGATCAGCTCCGCAGGGTGGCGCACGAGGTCGGCTTCTTCTATCTCGTCGGCCACGGCGTCCCACAGGATCTCGTCGACCGCGTGCTCACCGCCGCGCGTCGACTGTTCGCGCTGCCGCAGGCCGACAAGGACGCGATCGCGATGGTCAACAGCCCGCACTTCCGCGGGTACACGCGGCTCGGTGGTGAGCTGACCGGTGGCCAGGTGGACTGGCGCGAACAGATCGACATCGGACCCGAACGGGAGCCGCTGGACGATCCGGCAGAGCCGTATCTGCGTCTGCAGGGCCCGAACCAGTGGCCCGCGGCGCTGCCCGAACTGCCCGCTGTGATCGCCGAGTGGGACGCCGCGCTCGCGCAGGTGGGGCGCGCGTTGCTGCGTCACTGGGCCGTTGCCTTGGGCAATCCGGCCGACGTGTTCGACGAGGCGTTCGCCGACACCCCGGCCACGCTGATCAAGATCGTCCGGTATCCCGCGCAGGCCGAGACATCGCAGGGCGTCGGCGCCCATCGCGACGCCGGCGTGCTCACGCTGCTACTGGCCGAGCCAGGCAGCCGCGGACTGCAGGTCCGGGGCCCGGACGGGGTGTTCATCGACGTCGACCCCCTGCCGGGCGCGTTCATCGTGAACATCGGCGAGATGCTCGAGATCGCCAGCGGCGGCTACCTGCGGGCGACCGAACACCGGGTGCAGGTGAGCGCCTCCGAGCGCATCTCGGTGCCCTACTTCTTCAACCCGCGGCTCGACGCAGCCATACCAGTGCTCGCGCTTCCCGACGAACTGGCCGCGCAGGCCAGGGGCGTGACCGCGGACCCGTCGAACGACCGCATCTATTCGGTGTACGGGCGCAACGCCTGGAAGAGCCGCGTGCGTGCGCACCCAGATGTGGCAGCCGCTCACGGCTACGTGTGA	MPIRTLAVAGRLPDDGGVTALSTALPVVDLGDDAAVVTDQLRRVAHEVGFFYLVGHGVPQDLVDRVLTAARRLFALPQADKDAIAMVNSPHFRGYTRLGGELTGGQVDWREQIDIGPEREPLDDPAEPYLRLQGPNQWPAALPELPAVIAEWDAALAQVGRALLRHWAVALGNPADVFDEAFADTPATLIKIVRYPAQAETSQGVGAHRDAGVLTLLLAEPGSRGLQVRGPDGVFIDVDPLPGAFIVNIGEMLEIASGGYLRATEHRVQVSASERISVPYFFNPRLDAAIPVLALPDELAAQARGVTADPSNDRIYSVYGRNAWKSRVRAHPDVAAAHGYV	MRYIRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATIAERNQQIARIGAALIEHWQR	119.23	gnl|BL_ORD_ID|858|hsp_num:0	933			774	852	
